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The synthesis of cyclic dinucleotides as signals is one strategy bacteria use to sense and 
adjust to environmental changes. Cyclases synthesize the cyclic dinucleotide, while 
phosphodiesterases cleave it to yield a linear diribonucleotide, which is recycled into 
monoribonucleotides by other enzymes. For many bacteria, cyclic di-GMP (c-di-GMP) 
regulates the transition from a unicellular motile state to a multicellular sessile 
community. However, c-di-GMP signaling has been less intensively studied in Gram-
positive organisms. Bacillus subtilis is a model for the study of bacterial differentiation, 
yet how c-di-GMP functions in this organism is not fully understood. This work began 
with construction of a fluorescent reporter to measure c-di-GMP abundance in B. 
subtilis, which showed that c-di-GMP levels are strikingly different among 
differentiated subpopulations. These data highlight how single-cell approaches can be 
used to analyze metabolic trends within bacterial populations and demonstrate that for 
  
some bacteria, c-di-GMP levels are adjusted heterogeneously across bulk populations. 
The enzymes Orn, NrnA, NrnB, and NrnC have been proposed to act as general 3’-5’ 
exoribonucleases that preferentially process ‘short’ oligoribonucleotides. Intriguingly, 
Orn also performs a crucial role in c-di-GMP homeostasis by processing the pGpG 
generated from c-di-GMP production. To discover the molecular basis for Orn’s ability 
to ‘select’ short RNAs, and to elucidate the relationship between Orn and the 
diribonucleotide pGpG, we combined structural, biochemical, and in vivo analyses of 
RNA cleavage. These data reveal that Orn is not a general exoribonuclease of short 
RNA oligoribonucleotides, as previously believed, but instead acts as a dedicated 
‘diribonucleotidase’. Our studies indicate RNA degradation as a step-wise process with 
a dedicated enzyme for the clearance of diribonucleotides, which affect cellular 
physiology and viability. Examination of the roles of NrnA and NrnB is underway. We 
conducted an initial study to determine if NrnA and NrnB are redundant proteins, as 
has been proposed, and if they might also act as ‘diribonucleotidases’. These data show 
that they exhibit different substrate preferences and that they may have unique cellular 
functions. Therefore this work changes the perception of the role(s) Orn plays and that 
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Chapter 1: Introduction 
 
1.1 Copyright notice 
 Portions of the Introduction were originally published as: Weiss CA and 
Winkler WC. (2019). Cyclic di-GMP Signaling in Bacillus subtilis. In: Chou S-H, 
Guiliani N, Lee V, Römling, U (Eds.) Microbial Cyclic Di-Nucleotide Signaling. 
Switzerland: Springer Nature. In Press 
1.2 Bacterial nucleotide second messenger signaling 
 Bacteria occupy diverse niches, both within the surrounding environment as 
well as part of other multicellular organisms. As such, bacteria use diverse strategies to 
sense alterations in their environment and rapidly adjust to those changes. Several 
signal transduction strategies have evolved the use of different modular protein 
domains to integrate a sensory input with a corresponding regulated response  (1). 
These strategies have allowed for a complex systemwide network of bacterial 
signaling, and include the use of chemoreceptors, one and two-component systems, and 
phosphorelay systems, among others (2). Additionally, a number of nucleotide 
derivatives have been shown to serve as signaling molecules to coordinate bacterial 
behavior (3–7). These ‘second messengers’ are synthesized and hydrolyzed by proteins 
with conserved domains. Following synthesis, the second messenger can then go on to 
bind various receptors, also known as effectors, to target changes in bacterial 








Figure 1. Schematic diagram of second messenger and c-di-GMP signaling. (A) Second 
messenger signaling systems. (B) C-di-GMP is synthesized from 2 GTP molecules by 
diguanylate cyclases (DGCs) with GGDEF domains. Phosphodiesterases (PDE-As) hydrolyze 
c-di-GMP to pGpG, which is in turn hydrolyzed to 2 GMP molecules PDE-Bs. These include 



























 discovered in bacteria was cyclic 3’-5’ adenosine phosphate (cAMP) (8). cAMP 
signaling was found to regulate catabolite repression in Escherichia coli, thereby 
allowing the organism to preferentially utilize glucose before other sugars (9). 
Simultaneously, guanosine-(penta)tetraphosphate ((p)ppGpp) was shown to 
accumulate as growth rate decreased in E. coli and it is now a widely appreciated 
alarmone found in many bacteria critical for bacterial stress responses (10–13). Nearly 
twenty years later, the first cyclic dinucleotide, bis-(3′,5′)-cyclic diguanosine 
monophosphate (c-di-GMP), was discovered. Moshe Benziman and his colleagues first 
described c-di-GMP as an activator of bacterial cellulose biosynthesis (14). Since then, 
an ever-increasing number of studies have shown that c-di-GMP is a key regulator of 
lifestyle choice in bacteria.  C-di-GMP has been shown to promote adhesion and 
biofilm formation, while simultaneously preventing motility (15). C-di-GMP has also 
been shown to regulate a number of other phenotypes, such as cell cycle control and 
virulence (16, 17). The discovery of c-di-GMP prompted investigators to wonder if 
other cyclic nucleotide derivatives existed in bacteria. Indeed, the next second 
messenger to be identified was bis-(3′,5′)-cyclic diadenosine monophosphate (c-di-
AMP) (18). C-di-AMP has been shown to regulate very different processes, particularly 
in Gram-positive bacteria (19, 20). Cell wall homeostasis, ion transport, osmolyte 
uptake, DNA integrity, and biofilm formation have all been linked to c-di-AMP 
regulation (21–28). Sporulation-related processes may also be affected by c-di-AMP 
dynamics (29–31). Interestingly, unlike c-di-GMP, c-di-AMP signaling is essential 
under standard lab conditions in a number of bacteria including the model organism 





pneumoniae, Staphylococcus aureus, and Mycoplasma pneumoniae (32–35). 
Moreover, accumulation of c-di-AMP leads to cell death, suggesting that intracellular 
c-di-AMP levels are tightly regulated to control central processes.  
 Cyclic dinucleotides are also recognized by the innate immune system (36). 
Recent studies of c-di-AMP regulation of the intracellular pathogen L. monocytogenes 
revealed that c-di-AMP is secreted into the cytosol of host cells, which consequently 
elicits a type I interferon (IFN) response (37, 38). Yet two more cyclic dinucleotides 
based on cyclic GMP-AMP (cGAMP) exist and have also been implicated in host 
immunity. 3′,3′-cGAMP, synthesized from the enzyme DncV, was identified as a 
bacterial  second messenger that regulates chemotaxis and intestinal colonization in the 
bacterial pathogen V. cholerae (39). In mammalian cells, the enzyme cGAS synthesizes 
2′,3′-cGAMP, which has been shown to induce innate immune signaling and antiviral 
response cells via the receptor STING (stimulator of IFN genes) (40–42). STING was 
also shown to target c-di-GMP and c-di-AMP (43, 44). In addition to STING, DDX41 
was, until recently, the only other host receptor shown to induce a type I IFN response 
upon cyclic dinucleotide binding (45–47). However, a new receptor, the host 
oxidoreductase RECON, was shown to exhibit high affinity towards c-di-AMP and 
bacterial 3′,3′-cGAMP, but not mammalian 2′,3′-GAMP (48, 49). Investigations of 
nucleotide second messengers are continuing to reveal how second messenger 
signaling systems intersect, as observed during host immune responses.  
 Until recently, the only nucleotide signaling molecules discovered were purine 
derivatives. However, a new family of enzymes, cGAS/DncV-like 





pyrimidine nucleotides to synthesize a diverse range of cyclic dinucleotides (50). For 
example, CdnE was found to be one member of this family that synthesizes cyclic 
AMP-UMP, a hybrid purine-pyrimidine cyclic dinucleotide. Additionally, several CD-
NTases were shown to synthesize cyclic trinucleotides. The functional role of CD-
NTases, as well as the physiological outcomes of the cyclic di- and trinucleotides that 
they produce in bacteria and/or their host remain unexplored. 
 Bacteria oftentimes encode numerous enzymes and receptors for an individual 
signaling system (15). Furthermore, multiple second messenger signaling systems can 
be used. This suggests that the cell might experience a regulatory nightmare in 
establishing target specificity within each regulatory pathway; yet bacteria do not. This 
puzzle has been most extensively studied in the context of c-di-GMP signaling. One 
important mechanism that allows specificity of individual c-di-GMP metabolizing 
enzymes is through their regulation by sensory domains in response to specific 
environmental signals (51). The differential transcriptional regulation of some DGCs 
and PDE-As is also critical for establishing specificity of c-di-GMP signaling. While 
many DGCs and PDE-As are expressed under general laboratory conditions, several 
have been shown to be regulated during stress or particular growth phases in some 
bacteria, thereby allowing temporal regulation of c-di-GMP signaling (52–54). 
Additional studies have lent evidence to the idea of ‘local’ pools of c-di-GMP 
production, which are thought to allow spatial regulation of c-di-GMP signaling. In 
support of this, individual DGCs and PDE-As have been shown to regulate specific 
bacterial processes. For example, in a Salmonella enterica serovar Typhimurium strain 





stimulate cellulose biosynthesis (55). Additionally, the DGC DgcC in E. coli was 
recently shown to directly interact with proteins that make up the machinery for 
synthesis, secretion, and modification of cellulose biosynthesis (56, 57). A further 
example was also observed in B. subtilis, where a fluorescent fusion of the DGC DgcK 
colocalized with the effector YdaK, which in turn colocalized with proteins that 
synthesize a specialized polysaccharide (54, 58). Localization and binding studies of 
other pairs of DGCs and PDE-As, and c-di-GMP receptors in other organisms will 
continue to reveal the full extent of spatial regulation of c-di-GMP signaling.  
 The different binding affinities that receptors show for c-di-GMP is yet another 
way in which c-di-GMP can target specific bacterial processes. In support of this 
model, one recent study showed that in S. enterica serovar Typhimurium, deletion of 
PDE-A YhjH led to an increase in intracellular c-di-GMP that was sufficient to inhibit 
motility through the c-di-GMP receptor YcgR, but insufficient to stimulate cellulose 
synthesis through the receptor BcsA (59). The study further demonstrated that the two 
c-di-GMP receptors exhibited over a 40-fold difference in binding affinities for c-di-
GMP. Therefore, the range at which different receptors can bind c-di-GMP may allow 
for specific activation of certain receptors and subsequent biological targets. 
 How different second messenger systems interact with each other remains 
largely unknown. Yet, several studies have revealed connections among c-di-GMP, c-
di-AMP, (p)ppGpp, and cAMP signaling networks. For example, transcriptomic 
analysis recently showed that in V. cholerae, cAMP-binding transcription factor CRP 
regulates the expression of genes encoding c-di-GMP DGCs and PDE-As (60). 





the polysaccharide adhesin poly-GlcNac that induces biofilm formation (61). This 
suggests a model in which E. coli simultaneously monitors ribosome stress using 
(p)ppGpp signaling, while modulating c-di-GMP-regulated biofilm formation. Cross-
talk between (p)ppGpp and c-di-AMP was also recently observed. C-di-AMP 
accumulation was shown to induce the stringent response and stimulate (p)ppGpp 
synthesis in S. aureus, although the mechanism remains to be elucidated (62). 
Furthermore, (p)ppGpp was shown to be a strong competitive inhibitor of one class of 
c-di-AMP phosphodiesterases, GdpP (63). Other examples of cross-talk among other 
signaling systems and their effect on bacterial physiology undoubtedly await discovery. 
 
1.3 C-di-GMP synthesis and degradation 
 In response to environmental cues, c-di-GMP is synthesized from 2 GTP 
molecules by GGDEF domain-containing diguanylate cyclases (DGCs) (Figure 1B) 
(14, 64–68). The GGDEF motif represents the highly conserved active site (A-site), 
whereby 2 GTP molecules become linked via 2 3’-5’ phosphodiester bonds in a cyclic 
configuration. Following synthesis of c-di-GMP, the molecule can then bind several 
distinct classes of receptors that go on to mediate diverse phenotypes (69). C-di-GMP 
signaling is terminated by classes of phosphodiesterases (PDE-As) that contain 
conserved EAL or HD-GYP domains, which linearize c-di-GMP to the dinucleotide 5′-
phosphoguanylyl-(3′-5′)-guanosine (pGpG) (Figure 1B) (70–74).  GGDEF, EAL, and 
HD-GYP domains can be the only domains associated with DGCs and PDE-As or can 
also be found as part of multi-domain signaling proteins that include sensory domains 





translational regulation of DGC or PDE-A activity through activation by an 
extracellular signal. Furthermore, DGCs and PDE-As can also contain tandem 
arrangements of GGDEF and EAL domains, in which only one domain retains 
enzymatic activity (70, 80, 81). 
 
1.4 C-di-GMP receptors 
 While GGDEF or EAL/HD-GYP domain proteins alone are responsible for the 
synthesis and hydrolysis of c-di-GMP, there is a greater diversity of c-di-GMP 
receptors, including both RNA and protein factors. The first c-di-GMP receptor to be 
identified was the PilZ domain (82). Bioinformatic and phylogenetic analyses 
identified two motifs, RxxxR—D/NxSxxG, critical for c-di-GMP binding (83, 84). 
First identified as part of the BcsA subunit of the cellulose synthase complex in the 
Alphaproteobacteria Komagataeibacter xylinus (formerly Gluconacetobacter xylinus 
or Acetobacter xylinum), the PilZ domain is found within many other proteins and acts 
as an effector protein to allow c-di-GMP to target diverse processes (15, 82). For 
example, many Proteobacteria often use PilZ domain proteins, such as YcgR and DgrA, 
to inhibit flagellum-based motility in the presence of increased intracellular c-di-GMP 
(81, 85, 86). Conversely, c-di-GMP binding to the PilZ domain-containing protein 
BcsA activates cellulose synthesis to promote biofilm formation in a number of 
bacteria, including E. coli and S. enterica serovar Typhimurium (55, 87). 
 In addition to the PilZ domain, enzymatically inactive DGCs and PDEs with 
respective nonconsensus GGDEF- and EAL-domain active site sequences have also 





enzymatically inactive due to a degenerate catalytic A-site motif and have therefore 
lost the ability to synthesize c-di-GMP, but have retained the ability to bind c-di-GMP. 
Structural studies of GGDEF domain-containing proteins complexed with c-di-GMP 
revealed that many DGCs also have an additional c-di-GMP binding site, distinct from 
the A-site (93, 94). The residues that make up this allosteric inhibitory site (I-site), 
RxxD, are highly conserved in a number of active and inactive DGCs (95). For active 
DGCs, the I-site prevents overproduction of c-di-GMP by the DGC once a certain 
threshold has been reached. However, for enzymatically inactive proteins, the I-site 
allows these proteins to function as one class of c-di-GMP receptors.  
Not all c-di-GMP receptors can be easily predicted, as exemplified by the 
discoveries that c-di-GMP binds to certain transcription factors (96–101)  and to the 
protein MshE (102). This last receptor is a member of a family of ATPases that are 
associated with type IV pili and type II secretion systems. Simply put, it is difficult to 
accurately predict regulatory proteins that might bind c-di-GMP through bioinformatic 
approaches alone. The c-di-GMP binding proteins that have been identified have been 
found to exhibit significant differences in sequence and structure and individually 
required experimental analysis of c-di-GMP binding. Given the extensive regulation 
by c-di-GMP in bacteria, it is reasonable to suspect that other classes of receptors have 
yet to be identified. 
 Another large class of c-di-GMP receptors is comprised of noncoding RNA 
elements called riboswitches. Riboswitches are cis-acting regulatory RNAs that 
modulate downstream gene expression in response to changing intracellular metabolite 





dimensional shape that binds target metabolites with high affinity and selectivity, while 
the expression platform couples the ligand-induced conformational changes to control 
of downstream gene expression. To date, two distinct structural classes of c-di-GMP 
riboswitches, each characterized by a GEMM (Genes for the Environment, 
Membranes, and Motility) motif, have been discovered (104, 105). Over 500 examples 
of c-di-GMP riboswitches have been identified among diverse bacterial species (106). 
For example, c-di-GMP riboswitches are dispersed among Gram-positive Firmicutes 
such as Bacilli and Clostridia, as well as many Gram-negative Proteobacteria. 
Sequences have been identified in Bacillales such as B. cereus, B. thuringiensis, B. 
anthracis, and B. licheniformis, although none have been found in B. subtilis. Some 
bacterial species appear to be more replete in c-di-GMP riboswitches than others. For 
example, there are 16 different c-di-GMP riboswitches located across the 
Clostridioides difficile genome (107). Astoundingly, the Deltaproteobacterium 
Geobacter uraniireducens carries at least 30 c-di-GMP riboswitch elements. It should 
be noted that in some closely related species, Geobacter metallireducens and 
Geobacter sulfurreducens, a majority of the encoded GEMM-I riboswitches were 
shown to be selective for cGAMP (108).  This is in part due to a nucleotide change in 
the GEMM-I motif that can be found in about 20% of all predicted GEMM-I sequences. 
Therefore, it is possible that a subset of the GEMM riboswitches found in a given 
bacterium may also sense cGAMP and not c-di-GMP. In general, riboswitches are 
almost always found in the 5’ untranslated regions (UTRs) of mRNAs, and typically 
regulate gene expression by controlling formation of transcription termination sites or 





gene regulation by a c-di-GMP riboswitch was recently elucidated (110). One of V. 
cholerae’s two c-di-GMP riboswitches, Vc2, is encoded in the 5’ UTR of the tfoY gene 
(111). Further inspection, however, revealed that Vc2 resides within the 3’ end of a 
putative sRNA (P1-Vc2). Binding of Vc2 to c-di-GMP did not appear to regulate 
transcriptional termination, but rather, stabilized the presence of the putative sRNA, 
which lead to accumulation of the sRNA when intracellular c-di-GMP levels were high. 
When overexpressed, the sRNA was shown to enhance motility of V. cholerae 2.4 fold. 
C-di-GMP riboswitches are predicted to regulate expression of a broad array of 
functional gene categories, including but not limited to genes encoding 
GGDEF/EAL/HD-GYP proteins, flagella and pili, other motility factors, transcription 
factors, and membrane transporters (112). This diversity allows for the control of a 
complicated network of c-di-GMP-responsive changes in gene expression. Many 
associated genes, such as the ones in G. uraniireducens, code for proteins of unknown 
function, and therefore there is still far more to learn about the processes regulated by 
c-di-GMP. Furthermore, as more c-di-GMP riboswitches are discovered in other 
organisms, they will undoubtedly reveal new regulatory connections. 
 
1.5 Degradation of dinucleotide intermediates in bacteria 
 C-di-GMP signaling is terminated when c-di-GMP is hydrolyzed by a two-step 
process to the dinucleotide pGpG, followed by cleavage into nucleoside 
monophosphates (14). While pGpG was known to be hydrolyzed into two GMP 
molecules, the phosphodiesterase (PDE-B) that performed this terminal step remained 





could function as PDE-Bs and hydrolyze the diribonucleotide pGpG. A Differential 
Radial Capillary Action of Ligand Assay (DRaCALA) was used to screen an ORF 
library of Vibrio cholerae El Tor N16961 for proteins that bind pGpG (113). This 
screen identified Oligoribonuclease (Orn) as a protein that bound pGpG and not c-di-
GMP.  Originally discovered in the 1960’s, Orn was described as a 3’-5’ 
exoribonuclease responsible for processing short oligoribonucleotides 2 to 7 
nucleotides in length (114–117).  Subsequent investigations also found that: (1) Orn 
rapidly degraded pGpG in vitro, (2) lysates of Pseudomonas aeruginosa orn mutants 
were defective in PDE-B activity, and (3) loss of orn resulted in increased intracellular 
pGpG and c-di-GMP (113, 118). The accumulation of c-di-GMP due to loss of Orn 
results in several c-di-GMP-regulated phenotypes, due to feedback inhibition of PDE-
As by accumulation of pGpG. In summary, in addition to its perceived role as an 
oligoribonuclease, Orn was found to be the primary PDE-B responsible for pGpG 
hydrolysis to GMP, and therefore the terminal member in c-di-GMP signaling in 
bacteria.  
 Yet, Orn is not found in all bacteria. Accordingly, there has been interest in 
identifying if other proteins perform the same function as Orn. Orn is essential in a 
number of organisms, including E. coli (119). To bypass this essentiality, several types 
of conditional orn mutants were created to assess the genetic function of orn (119). In 
E. coli, expression of a conditional orn mutant resulted in pin-point sized colonies that 
stopped growing (120, 121). The ability to rescue this growth defect through 
complementation of gene candidates was used to identify functional analogs of Orn. 





positive organisms, preliminary studies focused on RNases encoded by B. subtilis that 
could heterologously complement the orn growth defect in E. coli. Two previous genes 
of unknown function were identified in B. subtilis—NanoRNase A (NrnA) and 
NanoRNase B (NrnB) (120, 121). Biochemical and functional characterization of NrnA 
and NrnB will be discussed further in Chapter 4. Evaluation of genomes in the 
Alphaproteobacteria, Chlamydiae, and Cyanobacteria phyla revealed that no Orn, 
NrnA, or NrnB homologs existed. Consequently, a genomic library of the obligate 
intracellular pathogen Bartonella birtlesii was screened for genes that can complement 
the E. coli conditional orn mutant (122). This led to the identification of NanoRNase 
C (NrnC), formerly BA0969. Subsequent biochemical characterization showed that 
NrnC readily degraded 5’Cy5-labeled 5mer RNAs. Unlike deletion of nrnA or nrnB in 
B. subtilis, knockdown of nrnC in Bartonella henselae did result in a growth defect. 
  Several bacterial phyla such as Firmicutes and Alphaproteobacteria were found 
to (1) not encode orn, (2) still utilize c-di-GMP signaling, and (3) encode functional 
Orn analogs. Therefore, researchers wanted to know if these functional Orn analogs 
also had the ability to cleave pGpG to terminate c-di-GMP signaling. To answer this, a 
similar orn complementation strategy was implemented in P. aeruginosa to determine 
which RNases could specifically hydrolyze pGpG (123). The deletion of orn in P. 
aeruginosa results in viable cells with several c-di-GMP dependent phenotypes such 
as enhanced biofilm formation and aggregation. Of the genes tested, only orn, B. 
subtilis nrnA and nrnB, and Caulobacter crescentus nrnC could reduce aggregation of 
the P. aeruginosa ∆orn strain. Biochemical data showed that these enzymes 





restored levels of intracellular pGpG and c-di-GMP to wild-type levels in a ∆orn strain 
as measured by mass spectrometry. In summary, a subset of RNases—namely Orn, 
NrnA, NrnB, and NrnC—serve as PDE-Bs and cleave pGpG.  
 In turn, c-di-AMP signaling is terminated in a similar fashion to c-di-GMP, 
where several classes of conserved phosphodiesterases hydrolyze c-di-AMP to pApA, 
before pApA is hydrolyzed into two AMP molecules (124). However, termination of 
c-di-AMP seems to be more diverse, as four different classes of c-di-AMP PDEs have 
been characterized and have different but overlapping enzymatic activities. Two 
classes, GdpP-type and PgpH-type PDEs are only able to convert c-di-AMP to pApA. 
For a time, it was unclear as to what other enzymes cleaved pApA to AMP. One class 
of c-di-AMP phosphodiesterases, DhhP-type however, combine the two step process 
and cleave cy-di-AMP to pApA and then hydrolyze pApA to AMP. Lastly, CdnP from 
the human pathogen Streptococcus agalactiae acts with a second nucleotidase NudP to 
degrade extracellular c-di-AMP to adenosine (45, 46). While no cGAMP-specific 
phosphodiesterases have been identified to date, it is likely that all cyclic dinucleotide 
signaling is terminated in a similar fashion, where a linear dinucleotide intermediate is 
formed prior to being recycled into nucleoside pools. Roles for Orn, NrnA, NrnB, and 
NrnC in c-di-AMP and cGAMP signaling systems, however, require further 
investigation. 
   
1.6 B. subtilis lifestyles 
 The ubiquitous soil species B. subtilis is the central model bacterium for the 





than 150 years ago, the intensive study of this microorganism as well as its genetic 
malleability have led to many fundamental discoveries, greatly improving the basic 
knowledge of bacterial biology. As early as 1877, Ferdinand Cohn had already 
described one of B. subtilis’ most enduring features: B. subtilis incorporates concepts 
of multicellularity into its bacterial communities (125, 126). Indeed, any culture of B. 
subtilis is likely to feature multiple, mutually exclusive subpopulations. The first cell 
type to be described by Cohn was sporulation, a process where vegetatively growing 
cells differentiate into metabolically inactive endospores. The genetic malleability of 
B. subtilis has allowed researchers to uncover many of the key molecular strategies that 
underlie this alternative life-style choice—for cells that will be encouraged into 
endospore formation, nutrient limitation stimulates a phosphorelay that results in 
phosphorylation of the master regulator Spo0A, which triggers the onset of sporulation 
(127, 128). Yet, endospore formation is not the only cellular differentiation pathway 
for this bacterium. For example, during exponential growth only a subset of cells is 
motile. These cells express the sigma factor SigD, which is required for activation of 
flagellar genes and motility (129). B. subtilis uses peritrichous flagella for two forms 
of motility: swimming and swarming. Swimming takes place autonomously through 
liquid, while swarming is a highly coordinated, social form of solid surface migration, 
only observed by undomesticated strains of B. subtilis (130, 131). Another distinct 
small proportion of the population corresponds to competent cells, which can 
proficiently import extracellular DNA, when activated by the transcription factor 
ComK (132, 133). Other cells within the population are triggered by regulatory proteins 





extracellular components that assist assembly of an extracellular matrix to promote 
biofilm formation (134, 135). Therefore, the B. subtilis community presents a 
population of genetically identical yet phenotypically distinct cells that presumably 
benefits from an efficient “division of labor,” by performing different tasks that 
optimize population survival (136–138).  
 The collective behavior of B. subtilis cell types is particularly evident during 
biofilm formation, in which these multicellular communities can be highly resilient to 
environmental stresses, due in part to the extracellular matrix that encases these cells 
(139, 140). In the lab, biofilms can form as colonies at the agar-air interface, or as 
floating communities at the liquid-air interface (pellicles). In both instances, these 
biofilms form architecturally complex morphologies. Biofilm formation begins when 
a subset of cells become activated for expression of genes required for extracellular 
matrix production. A major component synthesized by the subpopulation of matrix-
producing cells is exopolysaccharide (EPS) (141). In B. subtilis, the EPS is poly-N-
acetylglucosamine (PNAG), which is produced from proteins encoded by genes within 
the epsA-O operon, a long 15-gene cluster that is 16 kb in length (142). Matrix 
producers simultaneously produce TasA and BslA, which serve as structural protein 
components of the biofilm. TasA is a secreted protein that assembled into long fibers 
that are akin to amyloid fibers (143, 144). BslA has been shown to form a hydrophobic 
layer on the biofilm surface (145, 146). Indeed, both TasA and BslA are required for 
proper assembly of colony and pellicle biofilms (147). Many other extracellular 
components are produced during biofilm formation; other cells in the population 





signaling molecule to trigger a number of adaptive processes (148–150). Exoprotease 
production is also associated with an additional subpopulation and is believed to 
promote the acquisition of nutrients for the biofilm (151, 152). In addition to matrix-
producing cell types, a subset of the bacteria remains motile, and are thought to use 
flagellar motility to disperse from the biofilm to seed new environments (153, 154). 
Furthermore, spores are spatially organized within aerial structures toward the top of 
the maturing biofilm (140, 155). In summary, all of these different cellular 
subpopulations are likely to be critical for proper biofilm formation, and their formation 
is therefore tightly regulated at multiple levels (156–159).  
 C-di-GMP has been shown in many bacteria to regulate the transition from a 
unicellular motile state to a multicellular sessile community (15, 160). C-di-GMP 
signaling networks are encoded in almost every phylum in the bacterial domain, 
making this molecule a near-universal second messenger, although it has still been 
incompletely examined in several model microbes. The genetic malleability and wealth 
of knowledge regarding B. subtilis development make it an excellent experimental 
model in which to interrogate the contribution of c-di-GMP regulation to cell 
differentiation in Firmicutes.  
 
1.7 C-di-GMP signaling in B. subtilis 
1.7.1 C-di-GMP Metabolizing Enzymes in B. subtilis 
 Bioinformatic analysis has revealed that B. subtilis encodes three GGDEF-
domain proteins (YdaK, DgcK and DgcP), two EAL-domain proteins (PdeH and 





identified (Table 1). Three c-di-GMP protein receptors have been identified in B. 
subtilis to date: the PilZ domain-containing protein MotI, the degenerate GGDEF 
domain-containing protein YdaK, and the degenerate EAL domain-containing protein 
YkuI. Characterization of the enzymes and receptors involved in c-di-GMP signaling 
has been performed both biochemically and genetically. Diguanylate cyclase activity 
was confirmed biochemically for the purified GGDEF-domain fragments of DgcK and 
DgcP, as well as the dual GGDEF-EAL protein DgcW, which were all able to 
synthesize c-di-GMP in the presence of GTP (161). Diguanylate cyclase activities of 
DgcP and DgcW were enhanced when the respective GAF and PAS sensory domains 
were expressed and purified with the GGDEF domains. In contrast to DgcP and DgcW, 
DgcK does not appear to have an additional sensory domain. While DgcK, DgcP, and 
DgcW were catalytically active in vitro, YdaK was not (161). Further confirmation of 
these enzyme activities was acquired using mass spectrometry assays, where c-di-GMP 
levels were directly quantified from within appropriate cell extracts. For example, cell 
lysates from B. subtilis strains that overexpressed DgcK, DgcP, or DgcW exhibited 
elevated c-di-GMP relative to the wild-type strain. A number of experiments have 
shown that in B. subtilis, elevated c-di-GMP levels also leads to suppression of flagellar 
motility (161, 162). To assess the contribution of each individual DGC in B. subtilis, 
single deletions of GGDEF domain proteins (DgcK, DgcP, DgcW, and YdaK) were 
made. However, these mutants did not exert a strong effect on motility, likely due to 
some level of functional redundancy for the DGCs. A quadruple GGDEF mutant 

















Table 1.  Genes involved in B. subtilis c-di-GMP signaling 
Gene Prior Gene Names Domain Activity Biological Function 
dgcK yhcK GGDEF DGC Synthesizes c-di-GMP 
dgcW ytrP GGDEF DGC Synthesizes c-di-GMP 
dgcW ykoW GGDEF-EAL DGC Synthesizes c-di-GMP 
ydaK  GGDEF c-di-GMP binding Stimulates synthesis of an unknown EPS 
gdpP* yybT GGDEF ATPase c-di-AMP phosphodiesterase 
pdeH yuxH EAL PDE Hydrolyzes c-di-GMP 
ykuI  EAL c-di-GMP binding Zinc homeostasis 
motI ypfA/dgrA PilZ c-di-GMP binding Inhibits motility 
*Initially thought to be a nonconsensus GGDEF domain-containing protein involved in c-di-GMP 





in swarming compared to wild-type, individual overexpression of the active DGCs 
DgcP, DgcK, and DgcWΔEAL in this mutant background led to a reduction in 
swarming.The two EAL domain containing proteins PdeH and YkuI were also tested 
for phosphodiesterase activity in vitro (161, 163). C-di-GMP was hydrolyzed to the 
linear product pGpG only in the presence of purified PdeH, suggesting it is the only 
active PDE. Lysates from a ΔpdeH strain also exhibited higher levels of c-di-GMP, as 
measured by mass spectrometry. The role of PdeH as an active PDE-A was also 
demonstrated through its effect on motility. Specifically, deletion of pdeH caused a 
severe defect in swarming (161, 162). Together, these studies reveal that B. subtilis 
expresses the necessary enzymes for c-di-GMP signaling—namely, three diguanylate 
cyclases DgcK, DgcP, DgcW, and one phosphodiesterase PdeH (Figure 2A).  
 
1.7.2 C-di-GMP Regulation by MotI of B. subtilis Motility 
 C-di-GMP has been shown in a number of bacteria to inhibit flagellar rotation 
at the post-translational level (164, 165). In enteric bacteria such as E. coli and S. 
enterica serovar Typhimurium, one such mechanism has been investigated in great 
detail. Briefly, elevated c-di-GMP levels inhibit flagellar rotation through the PilZ 
domain-containing c-di-GMP receptor YcgR. Upon binding of c-di-GMP, YcgR 
undergoes a drastic conformational change that subsequently allows YcgR to directly 
interact with components of the flagella to slow down rotation (84, 166, 167). MotI 
(previously named YpfA and DgrA), exhibits an intact RxxxR—D/NxSxxG motif, 
consistent with the notion that MotI is a PilZ domain-containing c-di-GMP receptor 








Figure 2. Schematic diagram of c-di-GMP regulation in B. subtilis. (A) Diguanylate 
cyclases (DgcK, DgcP, DgcW) synthesize c-di-GMP from 2 GTP molecules. 
Phosphodiesterases (PdeH) hydrolyze c-di-GMP to pGpG, which is in turn hydrolyzed to 2 
GMP molecules by RNases NrnA and NrnB. C-di-GMP binds effectors (MotI, YdaK, YkuI). 
Putative functions and interactions of c-di-GMP effectors (B) MotI during motility, (C) YdaK 






similar function as YcgR in regulating the flagellar apparatus. Biochemical 
experiments supported a direct interaction between MotI and c-di-GMP: a combination 
of size exclusion chromatography and isothermal titration calorimetry revealed that 
MotI bound c-di-GMP with high affinity—with an equilibrium dissociation constant of 
11 nM (161). Furthermore, recent high-resolution structural studies revealed the 
molecular basis of c-di-GMP binding to MotI (168). The observed protein-ligand 
complex was similar to other PilZ domain-containing proteins such as PP4397 and 
Alg44 from Pseudomonas putida and Pseudomonas aeruginosa, respectively, in which 
two molecules of c-di-GMP bound between the N- and C-terminal domains of MotI 
(83, 169, 170). Overexpression of MotI resulted in a severe defect in swarming motility 
as compared to wild-type (161, 162). Swarming was completely abolished when MotI 
was simultaneously overexpressed in a ΔpdeH background, providing further evidence 
that the combination of MotI and elevated c-di-GMP levels negatively regulate 
motility. Conversely, this phenotype could be alleviated by deletion of MotI in a ΔpdeH 
background, suggesting that c-di-GMP regulation of flagellar motility in B. subtilis is 
primarily through MotI (162). Inhibition of swarming was also rescued similar to that 
of wild-type by site-directed mutagenesis of conserved binding site residues, thereby 
showing that the MotI c-di-GMP binding site is functionally relevant. In contrast, site-
directed mutations of residues outside of the c-di-GMP binding site did not alter MotI’s 
ability to inhibit swarming motility. In total, these results suggest that MotI represses 
B. subtilis motility when bound to c-di-GMP (Figure 2B). To identify MotI targets, 
bacterial two-hybrid assays showed that MotI interacts directly with the flagellar stator 





studies and suppressor analyses (168). Furthermore, mutations in the PilZ domain of 
MotI abolished its ability to interact with MotA. In B. subtilis, MotA is part of the 
MotA/B stator complex, which exploits the proton motive gradient to impart torque on 
the rotor, FliG. The torque on FliG subsequently generates force to the flagellum, 
allowing rotation. Therefore, MotI is thought to behave as a molecular clutch by 
disengaging the stator MotA’s contact with the rotor FliG (Figure 2B).  
 Unlike MotI, overexpression of the putative receptors YdaK or YkuI in a 
ΔpdeH background did not impact motility, suggesting that YdaK and YkuI may target 
other pathways in B. subtilis. 
 
1.7.3 C-di-GMP Regulation by YdaK of B. subtilis Biofilm Formation 
 Inhibition of motility due to elevated c-di-GMP levels also generally coincides 
with biofilm formation (15). Specifically, regulation of PNAG and other 
exopolysaccharides by c-di-GMP has emerged as a frequent theme among bacteria 
(172, 173). After all, the discovery of c-di-GMP by Moshe Benziman and his 
colleagues arose from their investigation of the regulation of cellulose synthesis in 
Komagataeibacter xylinus (formerly Gluconacetobacter xylinus or Acetobacter 
xylinum) (14). In the Gram-positive organism Listeria monocytogenes, 
exopolysaccharide biosynthesis was also shown to be increased in response to elevated 
c-di-GMP levels (174, 175). Yet it is not fully resolved whether c-di-GMP regulates 
exopolysaccharides for B. subtilis. While epsA-O gene expression is controlled by 
multiple transcription factors and signaling pathways, c-di-GMP does not appear to 





important for control of PNAG. Furthermore, no apparent change to B. subtilis biofilm 
colonies or pellicles has been observed upon mutation of the DGCs or PDE-As (161, 
162). While deletion of pdeH results in a swarming motility defect, it does not result in 
any obvious changes to biofilm colonies or pellicles. Overexpression of the DGCs did 
not appear to affect biofilms either, initially suggesting c-di-GMP is not important for 
control of biofilm formation in this organism. Recent data suggests that the degenerate 
DGC YdaK is a c-di-GMP receptor that is likely to participate in biofilms.  
 Inspection of the YdaK sequence revealed a nonconsensus GGDEF active site 
(A-site) motif. The presence of an intact I-site, but not an A-site, in YdaK suggests that 
it is an enzymatically inactive DGC that instead functions as a receptor. Consistent with 
this prediction, the purified nonconsensus GGDEF domain from YdaK bound c-di-
GMP with a Kd of 1.1 μM, but was unable to synthesize c-di-GMP (161). Furthermore, 
overexpression of YdaK in vivo did not result in detectable elevation of c-di-GMP, as 
compared to a wild-type strain. Future studies of YdaK complexed with c-di-GMP will 
resolve whether c-di-GMP binds to the inactive A-site, the RxxD I-site, or both 
locations. Recent data suggest that YdaK targets production of an as yet unidentified 
polysaccharide during biofilm formation.  
 The first clue that YdaK participates in biofilm formation arose from its 
genomic location within the ydaJKLMN operon (54, 58). Bioinformatics approaches 
proposed that members of some of the genes in the ydaJKLMN operon encode for 
exopolysaccharide synthesis machinery. Because manipulation of ydaK alone had no 
effect on biofilm formation or motility, the entire operon was overexpressed and 





staining. CR stains amyloid fibrils and some polysaccharides and it has therefore been 
employed previously as a reporter for measuring matrix production in biofilms and for 
indirectly measuring elevated c-di-GMP levels (143, 176, 177). Overexpression of 
ydaJKLMN resulted in enhanced CR-binding and a visible increase in colony rugosity, 
implying a change in extracellular matrix composition. Analysis of each gene encoded 
by the operon suggested that YdaLMN are involved in the synthesis of a new, but still 
unknown, polysaccharide product, which is likely to be modified by YdaJ (54). 
Furthermore, YdaK is required for the synthesis of the unknown polysaccharide by 
YdaLMN, suggesting that YdaK somehow activates production of the unknown EPS 
(Figure 2C). But is YdaLMN YdaK’s target? A fluorescent YdaK-YFP fusion appeared 
to co-localize with YdaM and YdaN at the cell poles and septa. This observation is 
somewhat reminiscent of the subcellular localization pattern of the large biosynthesis 
complex that produces the polyketide bacillaene (178). Also, deletion of one of the 
DGCs, dgcK, inhibited synthesis of the putative EPS machinery encoded by the yda 
operon, suggesting that the yda EPS is dgcK-dependent (58). Fluorescent DgcK fusions 
localized similarly to YdaK at the poles and septa, suggesting spatial proximity 
between the putative DGC-effector pair (Figure 2C). Intriguingly, the fluorescent 
YdaK reporter was observed in only a small subset of the population (~18.5%), 
suggesting that the yda operon is expressed in only a subpopulation of B. subtilis 
cultures (54). Furthermore, the yda operon is regulated by SigB, an alternate sigma 
factor induced in response to general cellular stresses (179). Together, these 
observations might suggest that the unknown yda EPS is stimulated during conditions 





1.7.4 C-di-GMP Regulation by YkuI of Other B. subtilis Pathways  
 To assess YkuI function (as a receptor or PDE), a ykuI mutant was tested for 
swarming motility (162). Compared to a pdeH mutant, deletion of ykuI only mildly 
impaired swarming. A mutant lacking both ykuI and pdeH resulted in inhibition of 
swarming motility to an extent that resembled the single pdeH mutation. Therefore, 
under the tested conditions, YkuI does not contribute significantly to inhibition of 
swarming. Recently, a transposon mutagenesis screen of wild-type B. subtilis cells 
revealed that insertion of transposons into ykuI conferred resistance to inhibitory 
(millimolar) concentrations of zinc (180). Yet, unlike other zinc resistance mutants, a 
ykuI mutant did not accumulate intracellular zinc, suggesting that inactivation of ykuI 
affects the metal indirectly. It is possible that deletion of ykuI somehow restricts access 
to zinc, although a mechanistic model for this phenotype has not yet been identified 
(Figure 2D).  
 Biochemical analysis of both the full-length and truncated EAL domain variants 
of B. subtilis YkuI failed to demonstrate PDE-A activity (163). The presence of an EAL 
domain, but lack of PDE-A activity in vitro allows it to potentially function as another 
c-di-GMP receptor. While many inactive PDE-As have degenerate active site 
sequences, intriguingly, YkuI has a perfectly intact active site sequence. Furthermore, 
high-resolution structural analyses of full-length YkuI confirmed binding of c-di-GMP 
to the EAL domain. Unlike other active PDE-As, however, the structure of YkuI 
revealed an alternate arrangement for D152, a residue involved in the coordination of 
a divalent cation for other PDEs. The lack of one metal ion might render the protein 





(PF10388) with a PAS-like fold. This PAS-like domain is found immediately adjacent 
to the EAL domain and is highly conserved in Bacillus species. Given that PAS 
domains frequently function as sensors, it remains possible that YkuI could still be 
activated for PDE-A activity with the appropriate PAS-like ligand.  
 Interestingly, B. subtilis YkuI has an ortholog in B. cereus group bacteria named 
CdgJ, which does have a degenerate EAL domain. Gene expression patterns of B. 
thuringiensis cdgJ showed an increase in expression during the transition from 
planktonic growth to biofilm (181). Subsequent overexpression of cdgJ resulted in 
increased biofilm formation and earlier entry into sporulation. Conversely, no 
sporulation was observed in a B. thuringiensis cdgJ mutant. Given the 55% identity in 
protein sequences between B. subtilis YkuI and B. thuringiensis CdgJ, it is therefore 
possible that YkuI might also exhibit a similar role in B. subtilis, although this has yet 
to be explored. 
 
1.8 Outlook 
 For many bacteria, c-di-GMP acts as an important intracellular signal to control 
lifestyle choice. In general, increased levels of c-di-GMP favors sessility and biofilm 
formation; correspondingly, decreased cellular levels of c-di-GMP promotes flagellar 
formation and motility (160, 182). While this theme has been established for Gram-
negative bacteria and is largely maintained in Gram-positive organisms, additional 
developmental lifestyles such as sporulation and competence offer new and exciting 





importance of B. subtilis as a model system for Firmicutes, there is a clear need to 
thoroughly examine the regulation by c-di-GMP signaling in this organism. Yet the 
methods used to examine whether c-di-GMP affects biofilm formation have thus far 
incompletely considered that B. subtilis biofilms are heterogeneously composed of 
several sub-populations. This study began with the creation of a fluorescent c-di-GMP 
sensor with which to assess intracellular c-di-GMP dynamics in single cells of 
differentiated sub-populations of B. subtilis, as described in Chapter 2.  
 Accordingly, the c-di-GMP intermediate, pGpG, has been shown in several 
organisms to be cleaved by Orn. In bacteria that do not encode Orn, other enzymes 
such as NrnA, NrnB, and NrnC are thought to perform this function in a redundant 
manner instead (123). However, Orn, NrnA, and NrnB have been described as general 
3’-5’ exonucleases of short ribonucleotides. Therefore, how these enzymes target short 
RNAs and participate in cyclic dinucleotide signaling remains an open area of 
investigation. We aim to understand mechanistically how RNases such as Orn, NrnA, 
and NrnB are able to selectively target pGpG, other linear dinucleotides, and/or longer 
RNA polymers. The mechanistic details of how Orn senses pGpG will be described in 
Chapter 3. Chapter 4 investigates if NrnA and NrnB are functionally redundant and are 
mechanistically similar to Orn. Elucidating the function of the RNases that have 
dinucleotidase activity will represent a significant advancement in cyclic dinucleotide 







Chapter 2: Single-cell microscopy reveals that levels of c-di-
GMP vary among B. subtilis subpopulations 
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2.2 Introduction 
 In many bacteria, c-di-GMP regulates the transition from a unicellular motile 
state to a multicellular sessile state (15, 160). However, c-di-GMP signaling has been 
less intensively studied in Gram-positive organisms as compared to their Gram-
negative counterparts. To visualize the relative abundance of c-di-GMP for single cells 
of the Gram-positive model organism B. subtilis, we sought to construct a genetic 
reporter of c-di-GMP levels based on a c-di-GMP-responsive riboswitch. The 
interaction between the riboswitch aptamer domain and its cognate ligand induces a 
conformational change in the structure of the transcript, or expression platform, that 





triggered by riboswitches most commonly arise from regulation of transcription 
attenuation or translation initiation. However, other mechanisms have been observed, 
such as regulation of mRNA stability and protein sequestration (103, 110, 184, 185). 
These “molecular switches” bind their ligand with exquisite affinity and specificity, 
thereby discriminating against closely-related ligand variants. Therefore, riboswitches 
may be attractive tools for imaging metabolic changes within individual bacterial cells. 
Several types of highly selective fluorescent c-di-GMP biosensors have been developed 
in recent years and have largely focused on interrogation of c-di-GMP dynamics in 
Gram-negative bacteria. Riboswitch aptamers have been used as allosteric regulators 
of the conditionally fluorescent Spinach RNA aptamer (186, 187). Spinach and 
Spinach2 aptamer RNAs fluoresce upon binding of 3,5-difluoro-4-hydroxybenzylidene 
imidazolinone (DFHBI) (188, 189). Spinach variants can be carefully fused to 
riboswitch aptamer domains such that the Spinach domain fluoresces only in response 
to binding of the riboswitch ligand (186, 190). Yet, while they exhibit ideal 
performance characteristics in vitro, they require further optimization for routine usage 
in bacterial cells. For example, Spinach-based biosensors exhibit lower fluorescence 
than common fluorescent proteins. Some researchers have circumvented this limitation 
by tagging targeted RNAs with up to 64 spinach aptamers in tandem, thereby increasing 
the brightness of tagged RNA molecules (191); yet, this approach is not ideal for 
biosensor purposes. Prior expression studies in Escherichia coli have required the 
addition of a tRNALys  scaffold sequence to aid in mRNA stability (192). Additionally, 
significant amounts of DFHBI have to be added to cells and allowed to incubate for 





passage through the cell membrane. A protein-based biosensor for c-di-GMP was also 
previously developed. The Salmonella typhimurium c-di-GMP binding protein YcgR 
was used to couple binding of c-di-GMP to Förster Resonance Energy Transfer (FRET) 
(193, 194). This genetically encoded biosensor protein was previously used for FRET-
based microscopy of Gram-negative organisms such as C. crescentus and P. 
aeruginosa (193, 195). However, FRET-based biosensors also exhibit lower 
fluorescence intensities compared to individual fluorescent proteins, which can result 
in an overall narrowing of their dynamic range. Furthermore, many c-di-GMP protein 
receptors remain to be discovered in Gram-positive organisms for use in FRET 
microscopy. Based on all of these considerations, we chose to pursue development of 
a riboswitch-yfp reporter fusion that could provide useful information on B. subtilis c-
di-GMP abundance. The fluorescent proteins used in this study have also been used in 
multiple studies regarding B. subtilis cell differentiation (196, 197). They have been 
shown to exhibit a shortened half-life and therefore can be expected to report relative 
differences in gene expression; however, it remains to be determined whether these 
reporters are sufficient to measure rapid dynamics.  
 A bioinformatics-based search (Rfam) for c-di-GMP-responsive riboswitches 
in Bacillales revealed a particularly interesting candidate in the untranslated leader 
region of the Bacillus licheniformis lch gene cluster. This nearly 27 kb operon (lchA) 
encodes the subunits of the nonribosomal peptide synthetase that makes lichenysin. 
Lichenysin is an antimicrobial cyclic lipopeptide that is virtually identical to surfactin, 





this riboswitch is particularly interesting given that riboswitches have not been 
previously analyzed as being important for genetic regulation of secondary metabolites.  
 Herein, we confirmed the function of the putative class-I lchAA c-di-GMP 
riboswitch in regulating downstream gene expression via transcription attenuation. 
Construction of the fluorescent riboswitch reporter and quantification of its expression 
in vivo revealed that c-di-GMP levels are markedly different among B. subtilis cellular 
subpopulations. To elucidate c-di-GMP dynamics in each subpopulation, the 
riboswitch reporter was coupled with fluorescent reporters that demarcate the primary 
classes of B. subtilis cell types. These reporters revealed that cells that have made the 
decision to become matrix producers maintain higher intracellular c-di-GMP 
concentrations as compared to motile cells. Similarly, we find that c-di-GMP levels are 
raised in sporulating cells and reduced in competent cell types. These results suggest 
that biochemical measurements of c-di-GMP abundance are likely to be inaccurate for 
a bulk ensemble of B. subtilis cells, as such measurements will average c-di-GMP 
levels across the population. This study therefore emphasizes the importance of using 
single-cell approaches for analyzing metabolic trends within ensemble bacterial 
populations. These data also demonstrate that for some bacteria, c-di-GMP levels are 











2.3.1 C-di-GMP attenuates transcription of the lchAA riboswitch in vitro 
 Many riboswitches couple detection of their target signal to transcription 
attenuation (103). In the unbound state, these riboswitches will oftentimes adopt a 
conformation in which an “anti-terminator” helix is created from the left half of the 
terminator and an upstream sequence. Then, when bound to its cognate ligand, the 
riboswitch will adopt an alternate conformation that allows for formation of an intrinsic 
terminator, causing disassociation of the transcription elongation complex. Manual 
inspection of the lchAA putative riboswitch revealed that its sequence included a 
candidate terminator site (Figure 3A). Therefore, to determine if c-di-GMP modulates 
downstream gene expression of the putative B. licheniformis riboswitch, a transcription 
termination assay was performed in vitro (Figure 3B). A DNA template of the lchAA 
untranslated element that included 50 nucleotides beyond the putative terminator (“run-
off”) was generated by PCR (Appendix) and mixed with RNA polymerase holoenzyme 
in the presence of varying amounts of c-di-GMP. Under the conditions that we used, a 
concentration of 10 µM c-di-GMP began to promote transcription termination at the 
terminus of the riboswitch, and ligand-responsive termination continued to increase up 
to the maximum concentration tested, 1 mM c-di-GMP.  
To directly measure binding of c-di-GMP to the lchAA riboswitch, the lchAA 
aptamer domain was identified via manual inspection and fused to the P2 stem loop of 
the Spinach2 aptamer (Appendix). We hypothesized this would create an allosteric 
version of Spinach2, thereby creating an RNA with two distinct binding sites, for which 













Figure 3. The lchAA riboswitch terminates in response to c-di-GMP. (A) Schematic of the 
mechanism of regulation by the B. licheniformis lchAA riboswitch in response to high and low 
levels of c-di-GMP. (B) A transcription termination assay of the lchAA UTR RNA with 
increasing concentrations of c-di-GMP (0 to 1000 µM) shows premature termination of run-
off (RO) within the leader sequence, as compared to a terminated (T) transcript. (C) Schematic 
of the Spinach2 RNA allosterically regulated by the lchAA riboswitch aptamer in response to 
c-di-GMP. (D) In vitro fluorescence assay of the riboswitch-Spinach2 RNA (100 nM) in the 
presence of saturating DFHBI (10 µM) and increasing concentrations of c-di-GMP or pGpG. 






DFHBI to Spinach2 (Figure 3C). To test if the molecule behaved as predicted, Spinach2 
fluorescence was measured in the presence of saturating concentrations of DFHBI and 
with increasing concentrations of c-di-GMP (Figure 3D). This revealed that 
fluorescence of the lchAA aptamer-Spinach2 RNA was dependent on an appropriate 
amount of c-di-GMP, confirming that the lchAA aptamer acts as a sensor of c-di-GMP. 
In contrast, we did not detect Spinach2 fluorescence in the presence of 100 µM c-di-
AMP. The lchAA aptamer, as part of a Spinach2 biosensor construct, bound c-di-GMP 
with an apparent Kd of 17 nM (Figure 3D). While this apparent Kd is much lower than 
the concentration of c-di-GMP required to promote transcription termination in vitro 
on purified DNA templates, there is a potential explanation for this difference. It has 
been previously observed that many riboswitches are not driven by equilibrium ligand 
interactions. Instead, they are driven by coordination of the kinetics of ligand 
association and RNA polymerization speed (201, 202). Therefore, one must be cautious 
in overinterpreting differences in equilibrium binding affinities for transcription 
attenuation-based riboswitches. If the lchAA riboswitch is kinetically driven, as we 
anticipate, a higher concentration of c-di-GMP would be required to promote a 
conformational change of the expression platform in vitro, as was suggested by our 
transcription termination data. Fluorescence of the lchAA-Spinach2 aptamer was also 
measured when the RNA was incubated in the presence of pGpG, the linear 
dinucleotide and c-di-GMP degradation product; however, the apparent Kd for this 
molecule was two orders of magnitude higher than that for c-di-GMP (Figure 3D). This 
roughly agrees with previous results on a different c-di-GMP riboswitch, which showed 





conclude from these aggregate data that c-di-GMP specifically interacts with the lchAA 
riboswitch to promote transcription attenuation of the lchAA operon. 
 
2.3.2 B. subtilis heterogenously expresses a lchAA riboswitch-yfp reporter 
 We next wanted to assess c-di-GMP levels in single cells of B. subtilis in vivo. 
The entire leader sequence of B. licheniformis lchAA was inserted between the 
constitutively active promoter sequence and yfp (Appendix). Unlike the constitutive yfp 
reporter, a strain containing the riboswitch-yfp reporter exhibited two prominently 
distinct levels of fluorescence within the population. Nearly 70% of the cells were 
moderately fluorescent as compared to the constitutive yfp strain, while the remaining 
cells exhibited significantly diminished fluorescence (Figure 4A, B). Therefore, unlike 
the unimodal distribution of fluorescence exhibited by the constitutive yfp reporter, the 
riboswitch-yfp reporter strain appeared to show a bimodal distribution of fluorescence. 
To determine whether this distribution was due to riboswitch regulation of YFP, the 
riboswitch element was mutated, so that 65 nucleotides from the 5’ end of the lchAA 
leader, which includes part of the c-di-GMP-binding aptamer, was removed. When 
examined for cellular fluorescence, this population of cells uniformly expressed YFP 
at levels similar to the constitutive yfp reporter construct (Figure 4A, C). These findings 
together suggest that the c-di-GMP riboswitch-yfp reporter is bimodally expressed 


















Figure 4. Expression of a lchAA riboswitch-yfp reporter in vivo results in bimodal 
distribution of fluorescence. (A) Representative microscopy images of wild-type B. subtilis 
PY79 expressing a constitutive Pconst-yfp reporter, a riboswitch reporter construct Pconst-
riboswitch-yfp, or a riboswitch reporter construct comprising a deletion corresponding to the 
riboswitch aptamer (Pconst-riboswitch∆apt-yfp). (B) Histograms of the quantification of 
fluorescence intensity per cell of wild-type B. subtilis PY79 expressing Pconst-yfp compared to 












2.3.3 The riboswitch reduces gene expression due to elevated c-di-GMP 
 To confirm that the bimodal distribution of fluorescence observed in single cells 
of B. subtilis was solely due to differences in intracellular c-di-GMP levels, we 
integrated the constitutive yfp and riboswitch-yfp reporter fusions into a ∆pdeH 
knockout strain. Loss of the PdeH phosphodiesterase should inhibit hydrolysis of c-di-
GMP and consequently elevate intracellular levels. We predicted that this should 
promote premature transcription termination in the riboswitch-yfp reporter fusion, 
thereby reducing YFP signal. Indeed, the riboswitch-yfp reporter resulted in 
significantly decreased yfp expression in the ∆pdeH background, suggesting 
intracellular c-di-GMP was elevated in all cells at late-log phase (OD600=1.0) (Figure 
5B, D). Conversely, constitutive yfp expression was unaffected by the ∆pdeH mutation, 
confirming the specificity of the riboswitch-yfp reporter for c-di-GMP (Figure 5A, C). 
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was also employed 
to detect c-di-GMP levels in both PY79 wild-type and ∆pdeH, grown to late-log phase 
(OD600=1.0). A roughly 3-fold increase in c-di-GMP was observed by LC-MS/MS for 
the bulk population of ∆pdeH cells (Figure 6).  
 
2.3.4 Expression of the riboswitch reporter correlates with specific cell types 
 We next sought to correlate c-di-GMP levels with subpopulations of B. subtilis. 
The gene encoding for yfp was replaced with another gene encoding for a red 
fluorescent protein, mCherry. This new riboswitch reporter was introduced in strains 






Figure 5. Deletion of pdeH results in increased c-di-GMP. (A) Representative microscopy 
images of B. subtilis PY79 wild-type (WT) or ∆pdeH expressing the constitutive Pconst-yfp 
reporter, or (B) the riboswitch reporter construct Pconst- riboswitch-yfp. (C-D) Histograms of 
the quantification of fluorescence intensity per cell comparing B. subtilis PY79 WT or ∆pdeH 



















Figure 6. LC-MS/MS detects increased c-di-GMP in B. subtilis ∆pdeH. Quantification by 
LC-MS/MS of intracellular c-di-GMP levels in B. subtilis PY79 wild-type (WT) or ∆pdeH in 
late-log phase (OD600=1.0). Results were obtained for two daughter ions. A roughly 3-fold 
increase in c-di-GMP was observed in ∆pdeH for daughter ion 1 (**P=0.0026) and daughter 
ion 2 (***P=0.0006) Error bars represent mean ± SD (n=3). Statistical significance determined 

































common B. subtilis cell types including: motile, matrix-producing, or competent. When 
analyzed by fluorescence microscopy at late-log phase (OD600=1.0), a majority of cells 
exhibited high expression of a Phag-gfp reporter (denoting motility) and high expression 
of the riboswitch-mCherry reporter (signifying low c-di-GMP). Of the cells that were 
transcriptionally active for motility gene expression, 89.8% also exhibited fluorescence 
from the riboswitch reporter. This suggests that c-di-GMP abundance is uniformly low 
in motile cells (Figure 7A, D), and that a positive correlation exists between the genetic 
reporters. Low c-di-GMP levels were also observed in competent cells. While roughly 
20% of cells in the population were competent, as indicated by a PcomG-yfp reporter, 
79.7% of these cells exhibited high fluorescence from the c-di-GMP riboswitch-
mCherry reporter (Figure 7C, F). However, when we analyzed the riboswitch-mCherry 
reporter in the context of matrix-producing cells, as identified by a PtapA-yfp reporter, 
we observed an anti-correlation between both reporters. Cells activated for producing 
extracellular matrix (as denoted by tapA gene expression) were observed mainly as 
long chains. Of these activated cells, 81.0% exhibited diminished fluorescence from 
the riboswitch-mCherry reporter (Figure 7B, E). This suggests that c-di-GMP levels 
are high in matrix-producing cells. Conversely, cells that showed high fluorescence for 
the riboswitch-mCherry reporter were almost never activated for tapA expression. 
Additionally, a small population of cells that had c-di-GMP levels sufficiently high 
enough to shut off the riboswitch reporter, but that had not activated the transcriptional 
reporter for biofilm formation (PtapA-yfp), was observed. It is possible that these cells 
had not been activated yet for extracellular matrix production, which might suggest that 








Figure 7. Expression of the riboswitch reporter varies nonrandomly among B. subtilis cell 
types. (A) Representative microscopy images of wild-type B. subtilis PY79 expressing the 
riboswitch reporter construct Pconst- riboswitch-mCherry and the motility reporter Phag-gfp. 
Statistical analyses show these reporters are significantly correlated (****P<0.0001). (B) 
Expression of Pconst- riboswitch-mCherry and the biofilm reporter PtapA-yfp are anti-correlated 
(**P=0.0039). (C) Expression of Pconst- riboswitch-mCherry and the competence reporter 
PcomG-yfp are correlated (****P<0.0001). (D-F) Quantification of the fluorescence intensity 
per cell of Pconst- riboswitch-mCherry compared to each cell type reporter in each construct 
(n~300). Dotted lines represent the cut-off that divides fluorescent cells from non-fluorescent 






reporter was also introduced in a strain that harbored a Pconst-mCherry reporter, so that 
c-di-GMP levels could be assessed in cells that were activated for sporulation. Cells 
that progressed through spore development maintained expression of mCherry, but 
were uniformly low in riboswitch-yfp expression, suggesting that c-di-GMP levels are 
high overall during endospore formation (Figure 8).   
  
2.3.5 An increase in c-di-GMP does not appear to change cell identity 
 To see if the manipulation of intracellular c-di-GMP levels could influence the 
proportion of cells that became matrix producers (as well as motile or competent), we 
used the “high c-di-GMP” strain, ∆pdeH, and integrated both transcriptional reporters 
for c-di-GMP levels and cell type in this background. When cells were analyzed by 
fluorescence microscopy, uniformly low mCherry levels of fluorescence were 
observed, thereby confirming the elevated levels of c-di-GMP in the ∆pdeH strain 
(Figure 9 A-F). Additionally, no obvious consequence on cell fate at the transcriptional 
level was observed. In many instances, however, c-di-GMP regulates phenotypic 
outputs at the post-translational level (164, 166, 167). This is exemplified in B. subtilis 
motile cells, where the binding of MotI to c-di-GMP directs MotI to directly disengage 
MotA from the rotor of the flagellar apparatus (168). It is possible that c-di-GMP post-
translationally regulates YdaK as well, and this interaction activates production of the 
unknown EPS. So, while the proportion of cells in each sub-type was consistent 
between the wild-type and ∆pdeH mutant, and the level of activation for motility 
(Figure 9A, D) and matrix (Figure 9B, E) gene expression as measured by the reporters 








Figure 8. High c-di-GMP levels correlate with sporulation. Representative microscopy 
images of a time course through sporulation of the wild-type B. subtilis PY79 expressing the 










Figure 9. Deletion of pdeH does not change expression of each cell type reporter. (A) 
Representative microscopy images of B. subtilis PY79 wild-type (WT) or ∆pdeH expressing 
the riboswitch reporter construct Pconst- riboswitch-mCherry and the motility reporter Phag-gfp, 
or (B) Pconst- riboswitch-mCherry and the biofilm reporter PtapA-yfp, or (C) Pconst- riboswitch-
mCherry and the competence reporter PcomG-yfp. (D-F) Quantification of the fluorescence 
intensity per cell of Pconst- riboswitch-mCherry compared to each cell type reporter, expressed 






differentiation at the post-translational level. Interestingly, mild repression of the 
competence transcriptional reporter was observed in the ∆pdeH strain as compared to 
wild-type (Figure 9C, F).  
 
2.3.6 pdeH expression is regulated transcriptionally  
 In addition to the catalytic EAL domain that provides phosphodiesterase 
activity, some PDEs also contain sensory domains (e.g. PAS) that allow for post-
translational regulation of phosphodiesterase activity through activation by an 
extracellular signal. No such domain has been identified in B. subtilis PdeH. However, 
pdeH transcription was previously suggested to be repressed by Spo0A (162, 204), 
indicating that pdeH might be regulated transcriptionally. We therefore sought to 
ascertain if heterogeneous expression of the riboswitch reporter was due to 
heterogeneous expression of pdeH in each cellular sub-type. A transcriptional fusion 
of the pdeH promoter to a reporter gene encoding Superfolder GFP (‘PpdeH-sf gfp’) was 
created and ectopically integrated into wild-type and ∆spo0A background strains. Mean 
fluorescence for the ∆spo0A background (0.162, 95% CI 0.158-0.167) increased by 
roughly 2-fold as compared to wild-type (0.086, 95% CI 0.082-0.090) (Figure 10A). 
This agrees with prior data showing Spo0A inhibition of pdeH expression (162). 
Furthermore, quantification of the PpdeH-sf gfp reporter revealed a single peak, implying 
a normal distribution of pdeH expression across the population. While a ∆sigD 
mutation had little effect on mean fluorescence (0.075, 95% CI 0.071-0.080) (Figure 







Figure 10. Deletion of global regulators affects pdeH expression and c-di-GMP levels. 
Quantification of the fluorescence intensity per cell of PpdeH-sf-gfp in B. subtilis PY79 wild-
type (WT), and (A) ∆spo0A, (B) ∆sinR, or (C) ∆sigD genetic backgrounds (n~300). 
Quantification and comparison of the fluorescence intensity per cell of Pconst- riboswitch-







mean fluorescence (Figure 10B). From this, we speculate that removal of SinR might 
lead to physiological changes that enhance activation of Spo0A, thereby maximizing 
the Spo0A-mediated inhibition of pdeH transcription. Alternatively, it is possible that 
SinR might activate expression of pdeH, directly or indirectly, through an unknown 
mechanism. We also quantified fluorescence from the riboswitch reporter in these 
genetic backgrounds to correlate c-di-GMP levels with activity from pdeH. Our data 
predicts that de-repression of pdeH due to ∆spo0A should lead to lower intracellular c-
di-GMP, exhibited by uniformly high fluorescence from the riboswitch reporter. 
Conversely, repression of pdeH due to ∆sinR should result in higher intracellular c-di-
GMP and result in uniformly lower fluorescence from the riboswitch reporter. As 
predicted, the riboswitch reporter followed the hypothesized trends. A ∆spo0A 
mutation led to loss of a bimodal distribution of fluorescence, and the population 
exhibited similar fluorescence to the “low c-di-GMP” population of wild-type (Figure 
10D). Mean fluorescence in a ∆sinR mutant was uniformly low (0.023, 95% CI 0.022-
0.023), indicating high intracellular c-di-GMP (Figure 10E). Unexpectedly, however, 
we observed uniformly low fluorescence from the riboswitch reporter in a ∆sigD 
background (0.029, 95% CI 0.028-0.030). This suggests ∆sigD cells have an increase 











 Given the importance of B. subtilis as a model system for the study of bacterial 
development, it is essential that its c-di-GMP regulatory mechanisms be further 
elucidated. In order to study c-di-GMP abundance for single cells of B. subtilis, we 
employed a constitutively expressed c-di-GMP riboswitch fused to yfp as our 
biosensor. Coupled with cell type-specific transcriptional reporters, our single cell 
microscopy shows definitively that intracellular c-di-GMP differs among B. subtilis 
cell types within a single population. Cells that have made the decision to become 
matrix producers maintain higher intracellular c-di-GMP as compared to motile cells. 
This study also shows that the transition into endospore formation correlates with high 
c-di-GMP levels, while competent cells correlate with lower c-di-GMP levels. This 
trend has not been previously examined in other studies.   
 One of the most common assays to measure the impact of mutations on biofilm 
formation, such as those affecting c-di-GMP homeostasis, is to visually assess the 
complexity of colony topology. While this can be qualitatively useful, it may not be 
representative of changes that occur at the cellular level. We take this to be due to the 
inherently heterogeneous composition of cell types within biofilm communities. 
Instead, the recent development of cell type-specific fluorescent reporters, as well as 
our c-di-GMP riboswitch reporter, allows investigators to examine features of B. 
subtilis subpopulations and their relationship to c-di-GMP effector proteins, DGCs, and 
PDEs. (51–53).  
Physiological roles have been determined for several of B. subtilis’ c-di-GMP 





162, 168). While the exact role of the yda operon has yet to be determined, the operon 
may be involved in the synthesis of an unknown exopolysaccharide, which may bolster 
the resistance of the biofilm during conditions of stress (54, 58). Our own analyses 
confirmed that pdeH is inhibited by the master regulator Spo0A, further establishing a 
connection between PdeH and c-di-GMP dynamics in specialized cell types during 
biofilm formation and/or sporulation. The roles of other enzymes and receptors, such 
as DgcK, DgcP, DgcW, and YkuI, remain to be elucidated. Single cell analyses are 
likely to be an important first step towards identifying the physiological conditions that 
activate c-di-GMP dynamics in a heterogeneous population of B. subtilis. For example, 
transcriptional data sets suggest that dgcW is regulated by sigma factor D, suggesting 
it may have a specialized role in motility. Future analyses of dgcW, in conjunction with 
visualization of our c-di-GMP riboswitch and cell type reporters, may help validate 
dgcW’s function. The yda EPS is thought to be dependent on DgcK (54, 58). If YdaK 
is paired with DgcK activity, is dgcK also induced by stress? Furthermore, what are the 
exact physiological conditions under which c-di-GMP and YdaK regulate YdaJLMN? 
Also, our riboswitch reporter could also potentially be used to help reveal if YkuI is 
indeed involved in the regulation of sporulation or zinc homeostasis. Assessment of c-
di-GMP abundance following deletion of ykuI could help determine whether YkuI acts 
as a c-di-GMP PDE or receptor. From these results, c-di-GMP riboswitch-yfp reporters 
could be used in other bacteria—Bacillales in particular—for single cell analyses of c-
di-GMP abundance. These riboswitch-reporters may prove to be useful tools in 
elucidating the increasingly diverse c-di-GMP regulatory mechanisms used by Gram-





 The study herein also shows that a c-di-GMP riboswitch is likely to control 
expression of a B. licheniformis lichenysin biosynthesis gene cluster. This observation 
suggests that in some bacteria antibiotic synthesis is under the purview of c-di-GMP 
signaling. By extension, these data suggest that surfactin biosynthesis could also be 
subjected to c-di-GMP regulation in other Bacillus species. Interestingly, a peptide 
essential for competence (ComS) is encoded within the surfactin operon srfAA-AD in 
B. subtilis (205). srfAA-AD is also regulated by the transcription factor ComA, which 
is ultimately activated by the quorum sensing molecule ComX (206–208). This 
regulatory arrangement allows B. subtilis to integrate a single signaling pathway into 
multiple adaptive processes. Prior studies have shown that surfactin-producing cells 
coexist with, but are phenotypically distinct from, cells that produce the extracellular 
matrix components (150). Therefore, our observation that c-di-GMP is low in 
competent cells implies that c-di-GMP should also be low for surfactin-producing cells. 
Indeed, the presence of the c-di-GMP riboswitch upstream of B. licheniformis lchAA 
operon indicates that lichenysin is only produced when c-di-GMP levels are low. 
ComA has been shown to also recognize the B. licheniformis lchAA promoter, further 
supporting a relationship between lichenysin and competence gene expression (209, 
210). While a c-di-GMP-responsive riboswitch does not seem to be located in the 
leader of B. subtilis srfAA, it is possible that c-di-GMP could regulate this gene cluster 
by an as yet undiscovered mechanism, which may foreshadow a role for c-di-GMP 
signaling during competence development in B. subtilis.  
 While our data demonstrate that c-di-GMP levels vary significantly between 





abundance is not likely to change the proportion of each cell type at the transcriptional 
level. Our data suggests that c-di-GMP metabolic enzymes act downstream of the 
master regulators that drive genetic regulation of cellular differentiation such as Spo0A 
and SinR (Fig 7A, B), and that in B. subtilis, changes in c-di-GMP abundance occur as 
a result of cellular decision-making. However, the molecular details of how c-di-GMP 
levels affect cellular differentiation require further exploration. Furthermore, it is 
possible that effector targets for c-di-GMP-binding proteins have yet to be identified, 
as might be suggested by the recently discovered link to the yda exopolysaccharide 
pathway. The regulatory mechanisms that dictate these pathways, as well as new 
candidates for c-di-GMP receptors, undoubtedly still await discovery. 
 
2.5 Materials and Methods 
2.5.1 Transcription termination assay 
 PCR amplification was performed on the B. licheniformis lchAA leader 
sequence using primers that place it downstream of a constitutive promoter Pconst and 
that ended 216 nts downstream of the transcription start site (Supp Fig 2). Transcription 
reactions were performed on the PCR-generated DNA template, resulting in a 
terminated (T) transcript of approximately 174-nt, or a 217-nt run-off (RO) transcript. 
These reactions comprised 5 µM template, 250 uM NTPs, 1X E. coli RNA Polymerase 
Reaction Buffer (NEB- 40 mM Tris-HCl pH 7.5, 150 mM KCl, 10 mM MgCl2, 1 mM 
DTT, 0.01% Triton X-100), 20 µCi a-32P-UTP, and 0.5 units of E. coli RNA 





reactions to a final concentration of 10 µM, 100 µM, and 1 mM. A 125-nt size marker 
was also transcribed. All reactions were incubated at 37˚C for 2 hours. Reactions were 
resolved by 6% urea-denaturing polyacrylamide gel electrophoresis (PAGE).  
 
2.5.2 Spinach activation assay 
 PCR was performed to amplify two aptamers: a tRNALys-lchAA-Spinach2 
template, and a tRNALys-Spinach 2 control template. A forward annealing primer was 
used to introduce the T7 promoter sequence, resulting in a 230-bp and 168-bp DNA 
template, respectively. Transcription reactions were performed, purified, and 
quantified as previously described (211). The in vitro Spinach2 fluorescence activation 
assay was modified from methods described previously (186). Briefly, the two RNA 
aptamers were each diluted to 2 µM and added to an equal volume of 2X renaturation 
buffer (80 mM HEPES pH 7.5, 250 mM KCl, 6 mM MgCl2), heated to 70˚C for 3 
minutes, and cooled at room temperature for 5 minutes. To test binding affinity of c-
di-GMP for the lchAA aptamer, binding reactions were prepared for each RNA aptamer 
(40 mM HEPES pH 7.5, 125 mM KCl, 3 mM MgCl2, 100 nM RNA, 10 µM DFHBI) 
and incubated in the dark at room temperature for 30 minutes. Stocks of c-di-GMP or 
pGpG were prepared and added to the binding reaction every 30 minutes to achieve the 
final concentrations that are graphed. Ligands were added until saturation of 
fluorescence was reached. A Quantusä Fluorometer (Promega) was used to excite the 
reaction at 495 nm every 30 minutes after incubation with increasing amounts of c-di-





replicated twice, and the background fluorescence of DFHBI alone was subtracted from 
all data points.  
 
2.5.3 Bacterial strains, plasmids, and growth conditions  
 All B. subtilis strains in this study are derived from PY79 (unless otherwise 
noted). Strains were grown at 37˚C on Lysogeny Broth (LB) plates supplemented with 
1.5% Bacto Agar and when appropriate, with final concentrations of the following 
antibiotics: 5 μg/mL chloramphenicol, and 1 μg/mL erythromycin added alongside 25 
μg/mL lincomycin (mls). Integration at the amyE locus was performed with plasmids 
derived from pJG019 (GenBank: KX499653.1), or pVMZ006, both derivatives of 
pDG1662 (BGSC). To construct pRSL_F4, the lchAA leader sequence was synthesized 
(GenScript) and subcloned into the HindIII restriction site of pJG019. For construction 
of the PpdeH-sf gfp reporter, the constitutive promoter of pVMZ006 was replaced with 
the pdeH promoter sequence that has been described previously (162). The sequence 
of sf- gfp was amplified from pJ204:102624 (DNA2.0, Inc.) and was used to replace 
the yfp sequence of pVMZ006 via Gibson assembly (212). The fluorescent 
transcriptional cell-type reporters Phag-gfp, PtapA-yfp, and PcomG-yfp that were used in 
this study have been described previously (135, 140, 213, 214). To construct the 
plasmids harboring these reporters, promoter sequences of tapA and comG were 
amplified from B. subtilis and used to replace the constitutive promoter upstream of yfp 
in pVMZ006 by Gibson assembly. The amyE::Phag-gfp fusion from DS4432 (provided 
by D. Kearns, Indiana University) was introduced into the PY79 chromosome through 





pDG1664 (BGSC) were used for integration at the thrC locus.  To make markerless 
deletions of ∆pdeH, ∆spo0A, ∆sinR, and ∆sigD, strains harboring an erythromycin-
resistance cassette inserted in loci BSU31740 (pdeH), BSU24220 (spo0A), BSU24610 
(sinR), and BSU16470 (sigD) were obtained from the BKE collection (BGSC).  
Markerless deletions were created through transformation with pDR244 (BGSC), as 
previously described (215). Removal of the erythromycin-resistance cassette was 
verified by Sanger sequencing. Transformation of PY79 was performed using a 
previously described protocol (216).  
 
2.5.4 Fluorescence microscopy and quantification 
 Single colonies were used to inoculate liquid MSgg medium (155) and grown 
at 37˚C shaking overnight. The following morning, cultures of each strain were 
inoculated 1:50 in fresh medium and grown at 37˚C shaking until reaching an optical 
density at 600 nm (OD600) of 1.0. Aliquots of these cultures were placed on 1.5% low-
melting agarose MSgg pads and allowed to dry for 10 minutes. Agarose pads were 
inverted onto a glass bottom dish (Willco Wells). Cells were imaged at room 
temperature using a Zeiss Axio-Observer Z1 inverted fluorescence microscope, 
equipped with a Rolera EM-C2 electron-multiplying charge-coupled (EMCC) camera, 
enclosed within a temperature-controlled environmental chamber. Fluorescence 
intensity per cell was quantified using Oufti analysis software (217). Images were 






2.5.5 Metabolite extraction of c-di-GMP in B. subtilis 
 Three independent replicates of B. subtilis PY79 WT and ∆pdeH::mls were 
grown overnight in liquid MSgg medium (155) shaking at 37˚C. The following day 
cultures of each strain were inoculated (1:50) into fresh MSgg and agitated at 37˚C 
until reaching an optical density at 600 nm (OD600) of 1.0. Metabolite extraction was 
performed as described previously (219). 5 mLs of each culture were passed through 
0.2 μm nylon filters (EMD Millipore). Metabolites were extracted by inverting the 
filters into petri dishes that contained 1.5 mL pre-chilled extraction solvent composed 
of 40:40:20 acetonitrile/methanol/water. Dishes were placed on dry ice for 15 minutes 
before the wash was collected and spun at max speed for 5 minutes at 4˚C. The 
supernatant was then placed in a vacuum centrifuge until metabolite extracts were dry. 
 
2.5.6 Detection and quantification of c-di-GMP by LC-MS/MS 
 Detection of c-di-GMP by LC-MS/MS was previously described (220). Briefly, 
bacterial extract was resuspended in Solvent A (10 mM tributylamine in water, pH 5.0) 
and centrifuged twice to remove insoluble particles. Metabolites were then separated 
on a Synergi Fusion-RP column (4 μm particle size, 80 Å pore size, 150 mm x 2 mm, 
Phenomenex) using a Shimadzu high performance liquid chromatography machine and 
simultaneously analyzed by a triple quadrupole mass spectrometer (3200 QTRAP, 
ABSCIEX). The total run time was 20 min at a binary flow rate of 0.5 ml min-1, with 
10 mM tributylamine in water (pH 5.0) as Solvent A and 100% methanol as Solvent B. 
The following gradient was performed: 0.01 min, 0% B, 4 min, 0% B, 11 min, 50% B, 





detected by multiple reaction monitoring (MRM) under negative mode using the ion 
pairs 689/79 and 689/344 (c-di-GMP). C-di-GMP was quantified using the Analyst® 
software (version 1.6.2) by calculating the total peak area and normalized by total ion 
current (TIC). Authentic c-di-GMP standards were injected and analyzed alongside 
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 C-di-GMP is widely used among bacterial phyla. Synthesized from 2 GTP 
molecules by diguanylate cyclases (DGCs) with conserved GGDEF domains, c-di-
GMP binds a diverse array of receptors that control numerous physiological outcomes 
(15). Hydrolysis of c-di-GMP to two GMP molecules occurs in a two-step process, 
with the linear diribonucleotide pGpG as an intermediate. The hydrolysis of c-di-GMP 
to pGpG is performed by conserved phosphodiesterases (PDE-As), that contain a 





into two GMP molecules, the phosphodiesterase (PDE-B) that performed this terminal 
step remained elusive for many years. It was previously proposed that HD-GYP 
domain-containing PDE-As might also perform this PDE-B function. Despite the 
genetic and biochemical evidence that heterologously expressed HD-GYP proteins 
from different organisms complement the function of EAL proteins in c-di-GMP 
hydrolysis, several biochemical experiments indicated the main product of c-di-GMP 
hydrolysis to be GMP, not pGpG (221). Furthermore, the HD-GYP protein PA4718 
was shown to have a 5-fold higher affinity for pGpG than c-di-GMP. The observation 
that not all bacteria that utilize c-di-GMP signaling encode HD-GYP domain-
containing proteins suggested that other enzymes could be responsible for the terminal 
step of c-di-GMP signaling. Consequently, a DRaCALA screen for pGpG-binding 
proteins was performed, which identified Oligoribonuclease (Orn) as the primary 
protein responsible for binding pGpG and cleaving pGpG to GMP (113). Subsequent 
studies showed that P. aeruginosa lysates corresponding to transposon mutants of two 
HD-GYP still retained the ability to cleave pGpG similar to wild-type. This suggested 
that HD-GYP PDE-As do not contribute to pGpG turnover in vivo.  
 Interestingly, several publications characterizing the role of Orn already existed 
(114–116). Orn was discovered in the 1960s, during some of the earliest investigations 
of RNA polymerization, decades before the discovery of c-di-GMP by Moshe 
Benziman and his colleagues. Shortly after the discovery of RNA Polymerase, great 
efforts were made to understand the properties and mechanisms of RNA Polymerase 
during transcription initiation. Although transcription initiation in all cells is dependent 





oligoribonucleotides could serve as templates for transcription by RNA Polymerase in 
vitro was well established (222, 223). While testing different oligoribonucleotides for 
priming activity with RNA Polymerase, Niyogi and Stevens observed that priming 
could only take place in the presence of purified RNA Polymerase. If crude extracts 
from E. coli were used, no priming activity was observed. This result suggested that 
there was something in the crude extract that interfered with the ability of 
oligoribonucleotides to stimulate RNA synthesis. Soon after, an enzyme fraction was 
isolated from E. coli and shown to hydrolyze adenine oligoribonucleotides to 5’-
adenosine monophosphate (5’-AMP) as the major product (114). Subsequent 
purification of the enzyme led to the characterization of Orn’s function. Since then, all 
available literature has assumed that Orn is a 3’-5’ exoribonuclease that is responsible 
for processing of short oligoribonucleotides 2 to 7 nucleotides in length (114–117). The 
ability of Orn to degrade the linear diribonucleotide pGpG therefore falls within the 
confines of Orn’s presumed function as an oligoribonuclease. Interestingly, Orn is 
essential for viability in a number of 𝛾-proteobacteria such as E. coli (119). This 
essentiality makes Orn unique among all other known 3’-5’ exoribonucleases, which 
have been shown in some instances to be functionally redundant.  
 The molecular basis of Orn’s unique cellular functions in 𝛾-proteobacteria that 
distinguishes it from all other exoribonucleases remained unexplained. Furthermore, it 
was not clear how Orn might selectively target ‘short’ RNAs, rather than simply 
binding to the penultimate sequence at the 3’ termini of single-stranded RNA of any 
length. The Winkler (University of Maryland), Lee (University of Maryland) and 





biochemical, genetic, and structural approaches. To that end, we incubated Orn with 5’ 
32P end-labeled RNAs of varying lengths and analyzed the products of that reaction 
over time. Our data show that Orn exhibits a surprisingly narrow substrate preference 
for diribonucleotides. We sought to understand this remarkable substrate selectivity of 
Orn by determining the crystal structure of Orn in complex with pGpG, which allowed 
us to identify key residues for recognizing diribonucleotides. Furthermore, we took 
advantage of the fact that P. aeruginosa orn mutants are still viable and found that Orn 
is the only diribonucleotidase in P. aeruginosa. The aggregate data shows that Orn 
exhibits such a striking preference for diribonucleotide substrates that the function of 
Orn as a general exoribonuclease should be reconsidered. 
 
3.3 Results 
3.3.1 Selection of a method to assess biochemical activity of Orn  
 Orn is presumed to function as a 3’-5’ exonuclease specific for small 
oligoribonucleotides. Prior studies employed chromatographic techniques, to be able 
to analyze the product composition of these reactions over time (115–117). Generally, 
14C-labeled (pA)n oligonucleotides 2-5 in length were incubated with purified Orn, 
other enzymes, or lysates. After the reaction was stopped, the reaction products were 
separated by paper chromatography and quantified by scintillation counting. Later 
studies relied on gel electrophoresis techniques. RNA substrates used in these studies 
were tagged at the 5’ terminus with fluorophores such as Cy5 (118, 120–122, 224). The 
products of this reaction were resolved by denaturing polyacrylamide gels, thereby 





end. To understand Orn’s substrate preferences, Orn would have to be purified and 
incubated with RNAs of varying lengths. Unlike fluorophore-labeled RNA used in 
prior studies, which contain a large planar chemical moiety at their 5’ terminus, we 
wanted to use substrates that resembled native ligands as closely as possible. To this 
end, native oligomers 2-7 ribonucleotides in length were synthesized, and the 5’ 
phosphate of each RNA was radiolabeled with 32P-𝛾-ATP, to ensure that the substrate 
structure was unperturbed. The diribonucleotide substrate in our subsequent studies 
was pGpG (GG), whereas the longer oligoribonucleotides included an increasing 
number of adenine nucleotides at the 5’ end. This arrangement ensured that the same 
GG sequence was maintained at the 3’ end while also avoiding stable G quadruplex 
formation that may be observed with RNAs containing stretches of poly-G (225).  
 The ability to analyze the product composition of these reactions over time 
would subsequently require chromatographic techniques to accurately resolve single 
nucleotide differences in RNA products from cleavage by Orn for quantitative analysis. 
Three assays that can perform this function were considered: thin layer chromatography 
(TLC), high performance liquid chromatography (HPLC), and gel electrophoresis. 
While TLC is the fastest method for separation, this method also offers the least 
sensitivity for accurately quantifying the relative accumulation of each product during 
Orn cleavage. Under the conditions we tested, we were not able to accurately 
discriminate among single nucleotide differences (Figure 11). In contrast, HPLC is 
likely to be a superior method in the separation of products, as it is sensitive and can 
be automated. It can be performed in a relatively short amount of time, accurately 






Figure 11. Resolution of single ribonucleotide species by PAGE or TLC. 5’ 32P- 
radiolabeled RNAs 2-7 nucleotides in length were generated and combined in a single mixture. 















However, HPLC requires larger amounts of starting material and was not immediately 
available to us. These considerations led us to find gel electrophoresis conditions that 
would separate RNA products with single nucleotide resolution. Prior studies used 
constituents that included 20% polyacrylamide and SDS as a denaturant. We chose to 
also use 20% polyacrylamide but chose to provide denaturing conditions from urea. 
Under these electrophoresis conditions, the mononucleotides and oligonucleotides that 
were tested (between 2 and 7 nucleotides in length) could be resolved (Figure 11).  
 
3.3.2 Orn functions as a diribonucleotidase in vitro   
 To understand the length preference of Orn, recombinant affinity-tagged Vibrio 
cholerae Orn (OrnVc) was purified and then tested biochemically. OrnVc was incubated 
with 5’-32P-radiolabeled oligoribonucleotides of varying lengths in the presence of 
magnesium, to support catalysis. Assays were also performed at near-physiological 
ionic strength, in contrast to prior studies that often utilized buffer lacking salt 
(NaCl/KCl). The products of these reactions were resolved by urea-denaturing 20% 
PAGE. At substrate concentrations that far exceed enzyme concentration (200:1), the 
diribonucleotide substrate was already fully processed to nucleoside monophosphates 
by 30 minutes (Figure 12A, B), which agrees with prior observations (113). In contrast, 
longer substrates (i.e. from 3-mers to 7-mers) were not processed at their 3’ end, even 
at 30 minutes (Figure 12A, B). These results suggest that Orn prefers dinucleotides. 
This strong substrate preference stands in stark contrast to previous studies arguing Orn 
acts as a general exoribonuclease that cleaves oligoribonucleotides with two to seven 










Figure 12. Orn has a stark preference for diribonucleotide cleavage in vitro. RNA 
nucleotides two to seven residues in length (1 μM, containing the corresponding 32P-labeled 
RNA tracer) were each subjected to cleavage over time with 5 nM (A, B) or 1000 nM OrnVc (C, 
D). Aliquots of each reaction were stopped at indicated times (min), and assessed by denaturing 
20% PAGE (A, C). Quantification of the intensities of bands corresponding to the amount of 
uncleaved initial oligonucleotide over time are plotted as the average and SD of three 





















To determine if Orn can indeed cleave substrates longer than a diribonucleotide, the 
enzyme was incubated with RNA substrates at a 1:1 molar ratio. Under these 
conditions, the diribonucleotide substrate was completely processed to nucleoside 
monophosphates by the earliest time point, 20 seconds (Figure 12C, D). OrnVc also 
facilitated the degradation of the longer RNA substrates, but only after significantly 
longer incubation times. For example, it required 10 minutes and 30 minutes to fully 
degrade 3-mer and 4-mer RNAs, respectively (Figure 12C, D). Cleavage was reduced 
further for longer RNAs; only 40–53% of the 5-mer, 6-mer and 7-mer RNAs were 
processed to nucleoside monophosphates at 30 minutes (Figure 12C, D). Of note, a 
non-uniform distribution of degradation products for the longer RNA substrates was 
observed. Specifically, the diribonucleotide intermediate was never observed as a 
reaction intermediate for the longer RNAs. This reaction pattern indicates that RNAs 
of more than two residues could accumulate, but that diribonucleotide RNAs were 
always rapidly processed to nucleoside monophosphates. Together, these results 
indicate that Orn exhibits a strong substrate preference for diribonucleotides over 
longer oligoribonucleotides – far greater than reported previously. 
 The relative substrate affinities of Orn to 5’-radiolabeled oligoribonucleotides 
that ranged from two to seven nucleotides in length was also determined (Table 2). For 
this, the Lee laboratory (University of Maryland) used an established ligand-binding 
assay, Differential radial capillary action of ligand assay (DRaCALA) (226). Briefly, 
protein and substrate are incubated and spotted on nitrocellulose membranes. At the 






















Table 2. Quantitative measurement of length-dependent oligoribonucleotide affinities. 
Substrate Dissociation constant (Kd) 
GG 90 -/+ 9 nM 
AGG 630 -/+ 80 nM 
AAGG 890 -/+ 90 nM 
AAAGG 2.56 -/+ 170 µM 
AAAAGG 3.83 -/+ 370 µM 
AAAAAGG 3.75 -/+ 530 µM 






allow unbound ligands to diffuse due to capillary action. By this assay, quantification 
of the diffusion zone reveals that OrnVc exhibits the highest affinity for 
diribonucleotides (Kd pGpG = 90 -/+9 nM), as compared to oligoribonucleotides of 
greater lengths (Table 2). Increase in the length to three or four residues reduced the 
affinity 7- or 10-fold, respectively. Substrates with five or more bases showed a greater 
than 28-fold reduction in affinity compared to diribonucleotides. The weak affinities 
determined for these substrates correlates with the weak nucleolytic activity observed 
by OrnVc. These results confirm that Orn has a strong preference for diribonucleotides 
over longer oligonucleotides.  
 
3.3.3 Orn cleaves all diribonucleotides  
 The ability to cleave pGpG suggests that Orn may also be able to cleave all 
other 15 diribonucleotide combinations. To test this, OrnVc was incubated with each 5’-
32P-radiolabeled diribonucleotide at a 200:1 substrate:enzyme molar ratio for 10 
minutes in the presence of divalent cations that support catalysis. The products of these 
reactions throughout the time course were resolved by urea-denaturing 20% PAGE 
(Figure 13). In 10 minutes OrnVc hydrolyzed di-purine substrates most efficiently, with 
90-95% of each substrate cleaved (Figure 13, pRpR). When provided with a mixed 
diribonucleotide in which a purine or pyrimidine base occupied either position, OrnVc 
cleaved 64-95% of these substrates. Diribonucleotides with a 5’ purine were 77-95% 
cleaved (pRpY). However, diribonucleotides with a 5’ pyrimidine exhibited 











Figure 13. OrnVc cleaves all diribonucleotides. (A) OrnVc (5 nM) was incubated with di-
purine (pRpR), purine-pyrimidine (pRpY or pYpR), or di-pyrimidine (pYpY) 
diribonucleotides (1 μM) containing the corresponding 32P-labeled RNA tracer. Aliquots of 
each reaction were stopped at the indicated times (min) and assessed by denaturing 20% PAGE. 
(B) Quantification of the intensities of bands corresponding to the amount of diribonucleotide 
cleaved at the 10 min time point. Results are the average and SD of duplicate independent 
experiments. Orn cleaves all diribonucleotides to nucleoside monosphosphates, albeit to 







In contrast, di-pyrimidine substrates showed the slowest turnover from the substrates 
tested, with only 40-75% of each di-pyrimidine substrate cleaved in the given time 
(pYpY). In particular, OrnVc cleaved 55% of pUpC and 40% of pCpC in 10 minutes. 
These aggregate data suggest that OrnVc cleaves all diribonucleotides to nucleoside 
monophosphates, albeit to varying extents. Furthermore, OrnVc exhibits a small but 
detectable preference for purine-containing substrates, in which a purine occupies the 
5’ position or both positions.   
 
3.3.4 The structure of pGpG-bound Orn reveals a unique active site  
 To elucidate the molecular basis for Orn’s substrate specificity, the 
Sondermann laboratory (Cornell University) determined Orn/substrate co-crystal 
structures. Two representative homologs, OrnVc (227) and the human REXO2 (also 
known as small fragment nuclease or Sfn) (228), were each crystallized bound to the 
diribonucleotide pGpG (Figure 14A, B). Superimposing the two structures indicates 
their identical fold. The pGpG-bound structures reveal a narrow active site that is lined 
by the conserved acidic residues of the signature DEDD motif (D12, E14, and D112 of 
OrnVc; D15, E17, and D115 of REXO2) and the general base H158 or H162 in OrnVc 
or REXO2, respectively (Figure 14A, B). In OrnVc, the bases of the diribonucleotide 
buttress against aromatic residues W61 and Y129, the latter being contributed from the 
second half-side of the dimeric enzyme. The corresponding residues, W64 and Y132, 
are conserved in REXO2. Residue L18 in OrnVc (L21 in REXO2) wedges in between 
the two bases. Most notably, residues S108, R130, S135 and the hydroxyl group on 








Figure 14. Structures reveal Orn’s conserved substrate preference for diribonucleotides. 
Crystal structures of pGpG-bound V. cholerae Orn (A) and human REXO2 (B) are shown in 
comparison to E. coli RNase T bound to substrate (PDB 3nh1) (C), another DnaQ-fold 3’−5’ 
exoribonuclease with a DEDD(h) active site motif. The top panels show ribbon representations 
of the dimeric enzymes. The insets are surface representations of the enzymes’ active sites 
shown in similar orientations. The bottom panel describes the active site residues involved in 
RNA binding and catalysis. Residue numbering for REXO2 refers to its cytosolic isoform 
lacking the mitochondria-targeting pre-sequence. The sequence logos in (D) were constructed 
based on multi-sequence alignments of Orn and RNase T orthologs. Sequence logos were 
plotted using WebLogo. Conserved residues of the active site’s DEDD motif (‘act.’; red), for 
ribonucleotide base binding (‘nuc.’; gray), and of the phosphate cap (‘P-cap’; purple) are 
highlighted. Performed by Sondermann Laboratory, Cornell University. Figure provided by 







phosphate of pGpG, capping the substrate. This phosphate cap creates a major 
constriction of the active site, which is not observed in structurally related 3’-5’ 
exoribonucleases such as RNase T or ExoI (Figure 14C) (229–231). RNase T and ExoI 
accommodate longer RNA substrates, facilitated by an expansive active site. The 
structural analysis correlates closely with sequence conservation of the phosphate cap 
motif, which is strict in Orn homologs but divergent in RNase T proteins (Figure 14D). 
The structural analysis also suggests that modifications at the bases may be tolerated. 
This is consistent with the observation that OrnVc can cleave all diribonucleotides.  
Together, the structural analysis uncovered Orn’s mode of substrate binding, which is 
conserved from bacteria to humans and indicates a unique selection for linear 
diribonucleotides with a 5’ phosphate. 
 
3.3.5 The phosphate cap and active site are required for Orn’s function 
            The structural analysis of pGpG-bound OrnVc allowed us to identify specific 
residues that might directly interact with the nucleotide. These residues were then 
individually mutagenized to assess the impact on catalysis of the phosphate cap or other 
interacting residues, in comparison to other active site residues (Table 3).  
Consequently, the Lee laboratory (University of Maryland) evaluated purified protein 
variants for pGpG degradation. As expected, mutations in the DEDD active site motif, 
such as D12A and H158A, led to complete loss of catalytic activity (Figure 15A, B). 
Mutations of the central phosphate cap residues Y129 and R130 to alanine also led to 
complete loss of catalytic activity, comparable to the DEDD active site mutants. 









Table 3. Mutations Constructed in OrnVc and Phenotypic Consequences.  
OrnVc 
Residue Proposed interaction 
Mutation 
Made Phenotypic Consequence 
D12 Catalytic residue 
DàA complete loss of activity 
(pGpG degradation) 
auto-aggregation 
L18 Separates bases, wedge 
LàA complete loss of activity 
(pGpG degradation) 
auto-aggregation 
D59 Interaction with 3’ bases 
DàA complete loss of activity 
(pGpG degradation) 
moderate auto-aggregation 
W61 Interaction with 3’ base, pi stacking 
WàA complete loss of activity 
(pGpG degradation) 
auto-aggregation 
W61 Interaction with 3’ base, pi stacking 
WàY turbid like wild-type 
H66 Interaction with 3’ phosphate HàA mildly cleaves pGpG turbid like wild-type 
Q111 Interaction with 5’ base QàA moderately cleaves pGpG turbid like wild-type 
Y129 Interaction with 5’ phosphate, pi stacking 
YàA complete loss of activity 
(pGpG degradation) 
auto-aggregation 
Y129 Interaction with 5’ phosphate, pi stacking 
YàW turbid like wild-type 
R130 Interaction with 5’ phosphate 
RàA complete loss of activity 
(pGpG degradation) 
auto-aggregation 
H158 Catalytic residue 









Figure 15. pGpG degradation by purified wild-type OrnVc or OrnVc variants. Functional 
importance of active-site and phosphate-cap residues for Orn function. 1 µM pGpG was treated 
with 5 nM of the indicated Orn protein and sampled at indicated time points to assess in vitro 
enzyme activity. Samples were stopped at the indicated times (min) and analyzed by denaturing 
20% PAGE. (A) Quantification of the means and SD of three independent experiments, of 
which (B) representative gel images are shown with the indicated RNA size. (C) Overnight 
cultures of the indicated strains were allowed to stand for 10 min without agitation to allow 
bacterial aggregates to sediment. Representative images of the cultures of triplicated assays are 
shown. Performed by Dr. Soo-kyoung Kim, Asan Turdiev, and Husan Turdiev, Lee Laboratory, 

















buttress). We next asked whether the OrnVc mutants could complement the deletion of 
orn in P. aeruginosa. P. aeruginosa ∆orn accumulates pGpG that in turn inhibits c-di-
GMP-specific phosphodiesterases (113, 118). As a net result, c-di-GMP accumulates 
in these cells, an effect that is associated with a hyper-biofilm and cell aggregation 
phenotype. While expression of wild-type OrnVc complements the P. aeruginosa ∆orn 
resulting in a dispersed culture, complementation with variants that carry mutations in 
either the active site (D12A) or phosphate cap residues (Y129A, R130A) results in cell 
aggregation indistinguishable from the ∆orn phenotype (Figure 15C). The ∆orn 
phenotype was also observed for L18A and W61A.  When Y129 and W61 were 
mutagenized to the converse aromatic residues, however, activity of Orn was restored, 
suggesting that the pi-stacking between the aromatic residues and each substrate base 
is critical (Figure 15C). Together, these experiments demonstrate that an intact 
phosphate cap, as well as other key interactions, are required for enzyme function. 
 
3.3.6 Orn is the only diribonucleotidase in P. aeruginosa  
 To determine Orn’s in vivo function as a general 3’-5’ exoribonuclease capable 
of degrading short oligoribonucleotides or as a diribonucleotidase, the Lee laboratory 
(University of Maryland) developed experimental conditions to measure Orn’s activity 
in cellular extracts. The orn gene is essential in most 𝛾-proteobacteria; however, it is 
not essential for growth of P. aeruginosa under most conditions (69, 70). Therefore, 
lysates were generated from P. aeruginosa strains, including parental PA14, ∆orn, and 
∆orn complemented with ornVc. 5’-32P-radiolabeled 2-mer or 7-mer RNA was then 





throughout the time course and analyzed by urea denaturing 20% PAGE. Extracts from 
parental PA14 digested the entire radiolabeled diribonucleotide in less than 5 minutes 
(Figure 16A). In contrast, lysates from strains lacking Orn failed to show any signs of 
diribonucleotidase activity even at longer time points. Similarly, complementation with 
a catalytically inactive allele of orn, orn D12A, also failed to clear the diribonucleotide 
(Figure 16A). Diribonucleotidase activity in the lysates could be restored by ectopic 
expression of orn from a self-replicating plasmid or by addition of purified Orn (Figure 
16A). When the 32P-7-mer RNA substrate was incubated in extracts from parental 
PA14 it was digested to a ladder of degradative intermediates including 6-mer, 5-mer, 
4-mer and 3-mer RNAs (Figure 16B). Of note, while these intermediates and the final 
mononucleotide product accumulated over time, the 2-mer intermediate was never 
observed over the time course. In contrast, lysates from the ∆orn mutant specifically 
accrued the diribonucleotide intermediate with no apparent production of its 
mononucleotide products. Ectopic expression of plasmid-borne orn, but not orn D12A, 
restored the degradation of the 7-mer to mononucleotides and the diribonucleotide 
intermediate could no longer be observed. Furthermore, the diribonucleotide 
intermediate that accumulated in the ∆orn lysate was fully processed upon addition of 
purified Orn protein (Figure 16B). Together, these results show that P. aeruginosa 
accumulates diribonucleotide intermediates in a ∆orn background, which is only 
resolved upon addition of Orn. Degradation of RNA fragments with three or more 
residues by Orn was not observed in a cellular context, considering that ∆orn lysates 
preserve nuclease activities for the processing of RNAs down to diribonucleotides. 














Figure 16. Orn acts as a diribonucleotidase in cell lysates. Degradation of 32P-GG (A) 
and 32P-AAAAAGG (B) by whole cell lysates of wild-type, orn mutant, orn mutant 
complemented with ornVc, or ornVc D12A. For ∆orn and ∆orn complemented 
with ornVc D12A,100 nM of purified OrnVcwas added at 30 min time point and incubated for an 
additional 10 min. Samples were stopped at the indicated time and analyzed by 20% denaturing 
PAGE. Representative gel images of triplicated assays are shown with the indicated RNA size. 
Graphs show quantitation of triplicate data for indicated RNA species over time. Performed by 











 Bacteria use a variety of different RNases to carry out mRNA turnover (232). 
Furthermore, the individual mechanisms that bacteria use to accomplish this have 
profound effects on gene expression, environmental adaptation, and indeed, cellular 
viability. The action of individual RNases is transcript specific, and triggered by 
sequence specificity and structure, among other things. The data provided above 
proposes a general model of RNA degradation, wherein following endonucleolytic 
cleavage of RNA, a combination of exoribonucleases process RNA down to 
diribonucleotides and Orn completes RNA recycling by cleaving diribonucleotides to 
nucleoside monophosphates. The presented study shows that the substrate specificity 
for diribonucleotides appears to be driven by an active site that is enclosed by a “cap” 
that has multiple interactions with the 5’ phosphate of diribonucleotide substrates. The 
constricted active site prevents longer substrates from binding with high affinity, 
rendering them poor substrates for catalytic cleavage. 
 Orn is unique amongst exoribonucleases because it is essential in some 𝛾 -
proteobacteria and is required to degrade the pGpG intermediate in c-di-GMP 
signaling. Yet, c-di-GMP signaling is not essential for viability. While the molecular 
mechanism underlying this essentiality has yet to be explored, the mechanism for 
essentiality should not be c-di-GMP. Rather, it is likely that the accumulation of 





shown that orn depletion can lead to accumulation of diribonucleotides and longer 
oligoribonucleotides in some cellular backgrounds (119, 233). In our own studies, both 
di- and tri-ribonucleotides accumulated in RNA cleavage assays of the P. aeruginosa 
orn mutant. The increase in oligoribonucleotides longer than dimers in cells could 
occur through feedback inhibition of other RNases, analogous to the feedback 
inhibition of c-di-GMP linearization by PDE-As, thereby preventing cleavage. 
Alternatively, accumulation of pGpG might lead to specific off-target interactions with 
essential proteins. For example, c-di-GMP has been implicated in the regulation of 
ribosome modification. In Pseudomonas species, RimK is a glutamate ligase that 
modifies ribosomal protein S6 (RpsF) by the addition of glutamate residues to the C-
terminus (234). RimK has also shown to be a c-di-GMP receptor that interacts with two 
additional proteins: a poly-glutamate protease RimB, and the c-di-GMP PDE-A RimA. 
The modification of RpsF has been shown to result in altered Hfq abundance, although 
the mechanisms by which this takes place is not yet clear. Hfq is an RNA chaperone 
that is crucial to mRNA/sRNA stability, translation, and post-transcriptional regulation. 
Indeed, a deletion of rimK resulted in significantly lower abundance of ribosomal 
proteins, reduction in Hfq and an increased stress response (234, 235). If pGpG inhibits 
c-di-GMP linearization by PDE-A RimA in a similar fashion to other Pseudomonas 
PDE-A’s, accumulation of pGpG may have detrimental consequences to ribosomal 
function, leading to an altered proteome profile. Therefore, the extent to which c-di-
GMP, and by extension pGpG, fine-tune ribosome function and control Hfq levels 
remains an important open question. Another possibility is that the accumulation of 





evidence that 2- to 4-nucleotide long RNAs prime transcription initiation in E. coli. 
Transcription initiation due to elevated levels of these short RNAs resulted in global 
alterations in gene expression due to shifting of transcription start sites (233). 
Therefore, alterations in transcription initiation could result in cellular toxicity (236, 
237). Our studies reveal a discrete step in RNA degradation—the enzymatic cleavage 
of diribonucleotides into mononucleotides—and require further investigation into how, 
mechanistically, diribonucleotide accumulation is detrimental to cell survival. While 
our evidence on the true molecular function of Orn is important, it is only the beginning.   
 
3.5 Materials and Methods 
3.5.1 Bacterial strains, plasmids, and growth conditions 
 P. aeruginosa is routinely grown in LB supplemented with the appropriate 
antibiotic (50 mg/mL carbenicillin or 75 mg/mL gentamicin) at 37°C. To create the 
point mutants of ornVc, mutations were generated by using the Q5 Site-Directed Muta- 
genesis Kit (New England Biolabs). All mutations were verified by sequencing. 
 
 
3.5.2 Protein expression and purification for protein crystallography 
 orn genes from V.cholerae O1 El Tor VC0341 (residues 1–181) and Homo 
sapiens REXO2 (residues 33–237) were synthesized by Geneart (Life Technologies). 
Genes were cloned by ligation between BamHI and NotI sites of a modified pET28a 
vector (Novagen) yielding N-terminally His6-tagged small ubiquitin-like modifier 





overexpressed in E. coli BL21 T7 Express cells (New England Biolabs). Fresh 
transformants were grown in Terrific Broth (TB) supplemented with 50 ug/mL 
kanamycin at 37°C to an OD600 ~1.0, at which point the temperature was reduced to 
18°C and expression was induced by addition of 0.5 mM IPTG. Cells were harvested 
after 16 hours of expression by centrifugation and resuspended in a minimal volume of 
Ni-NTA binding buffer (25 mM Tris-Cl, 500 mM NaCl, 20 mM imidazole, pH 8.5) 
followed by flash freezing in liquid nitrogen. Cells were thawed and lysed by 
sonication. Cell debris was removed by centrifugation and clarified soluble lysate was 
incubated with Ni-NTA resin (Qiagen) pre-equilibrated with Ni-NTA binding buffer. 
Following one hour of binding, the resin was washed three times with 10 column 
volumes of Ni-NTA binding buffer, and then eluted with six column volumes of Ni-
NTA elution buffer (25 mM Tris-Cl, 500 mM NaCl, 350 mM imidazole, pH 8.5). 
Eluates were buffer exchanged into gel filtration buffer (25 mM Tris-Cl, 150 mM NaCl, 
pH 7.5) via a HiPrep 26/10 desalting column (GE Healthcare), followed by overnight 
incubation with Ulp-1 to cleave off the His6-tagged SUMO moiety. Untagged Orn 
proteins were recovered in the flow-through of a HisTrap Ni-NTA column (GE 
Healthcare), separated from His6-SUMO, uncleaved proteins and His6-tagged Ulp-1. 
Orn was concentrated via Amicon Ultra 10K concentrator prior to loading onto a 
HiLoad 16/60 Superdex 200 gel filtration column GE Healthcare) equilibrated in gel 
filtration buffer. Fractions containing Orn were pooled and concentrated to 100 mg/mL, 






3.5.3 Protein crystallography and data deposition 
 REXO2-RNA and OrnVc-RNA complexes (pGpG and pApA from BioLog 
Life Science Institute, other nucleotides from GE Healthcare Dharmacon) were formed 
prior to crystallization by mixing a 1:2 molar ratio of Orn:RNA in gel filtration buffer, 
followed by incubation for 30 minutes at the crystallization temperature. Orn-RNA 
complexes (10–30 mg/ml) were crystallized via hanging-drop vapor diffusion by 
mixing equal volumes (0.8 mL) of sample with reservoir solution. OrnVc crystals grew 
at 20°C over a reservoir solution that was composed of 0.1 M BisTris (pH 5.5), 17% 
polyethylene glycol 3350, and 20% xylitol. Crystals were flash-frozen in liquid 
nitrogen. REXO2 crystals grew at 4°C, using a reservoir comprised of 0.2 M sodium 
malonate (pH 5.5) and 15–20% polyethylene glycol 3350. REXO2 crystals were 
soaked in cryoprotectant of reservoir solution supplemented with 25% glycerol prior to 
flash freezing with liquid nitrogen. All crystals were stored in liquid nitrogen. Data 
were collected by synchrotron radiation at 0.977 A° on frozen crystals at 100 K at 
beamline F1 of the Cornell High Energy Synchrotron Source (CHESS). Diffraction 
data sets were processed using XDS, Pointless, and Scala. The initial structures were 
solved by Molecular Replacement using the software package Phenix and the 
unpublished coordinates of E. coli Orn (PDB: 2igi) as the search model. Manual model 
building and refinement were carried out with Coot and Phenix, respectively. 
Illustrations were prepared in Pymol (Version 2.2.0, Schrodinger, LLC). All software 
packages were accessed through SBGrid. The atomic coordinates and structure factors 
have been deposited in the Protein Data Bank, www.rcsb.org (PDB ID codes 6N6A, 





3.5.4 Protein expression and purification for biochemical assays 
 E. coli T7Iq strains harboring expression vector pVL847 expressing an His10-
MBP-Orn and His10-MBP-Orn mutants from V. cholerae were grown overnight, 
subcultured in LB M9 fresh media supplemented with 15 mg/ml gentamicin and grown 
to approximately OD600 0.5 ~ 1.0 at 30°C. Expression was induced with 1 mM IPTG 
for 4 hours. Induced bacteria were collected by centrifugation and resuspended in 10 
mM Tris, pH 8, 100 mM NaCl, and 25 mM imidazole. After addition of 10 mg/mL 
DNase, 25 mg/mL lysozyme, and 1 mM PMSF, bacteria were lysed by sonication. 
Insoluble material was removed by centrifugation. The His-fusion protein was purified 
by separation over a Ni-NTA column. Purified proteins were pooled and dialyzed for 
1 hour and overnight against 10 mM Tris, pH 8, 100 mM NaCl. The proteins were 
dialyzed for 3 hours in 10 mM Tris, pH 8, 100 mM NaCl, and 50% (vol/vol) glycerol, 
aliquoted, and flash frozen with liquid nitrogen and stored at -80°C. 
 
3.5.5 Labeling of RNAs 
 5’ un-phosphorylated RNAs were purchased from TriLink Biotechnologies or 
Sigma. Each RNA was subjected to radioactive end-labeling or non-radioactive 
phosphorylation by T4 Polynucleotide Kinase (New England Biolabs). Each RNA was 
subjected to phosphorylation with equimolar concentrations of either 32P-gammaATP 
or ATP, T4 PNK, and 1X T4 PNK Reaction Buffer. Reactions comprising a final 
concentration of either 0.5 µM radiolabeled RNA or 2.0 µM phosphorylated RNA were 






3.5.6 Purified Orn cleavage reactions 
 Phosphorylated RNA (1.0 µM), including trace amounts of radiolabeled 
substrate, was subjected to cleavage by either 5.0 nM or 1.0 µM purified Orn at room 
temperature. These reactions were in the presence of 10 mM Tris, pH 8.0, 100 mM 
NaCl, and 5 mM MgCl2. At the appropriate times, aliquots of the reaction were 
removed and quenched in the presence of 150 mM EDTA on ice and heat inactivated 
at 95°C for 5 min. Samples were separated on denaturing 20% PAGE containing 1X 
TBE and 4 M urea. The gels were imaged using Fujifilm FLA-7000 phosphorimager 
(GE) and analyzed for the appearance of truncated 32P-labeled products. The intensity 
of the radiolabeled nucleotides was quantified using Fujifilm Multi Gauge software 
v3.0. 
 
3.5.7 Whole cell lysate cleavage reactions  
 Activity of whole cell lysates against 32P-labeled oligoribonucleotide substrates 
was performed at room temperature in reaction buffer (10 mM Tris, pH 8, 100 mM 
NaCl, and 5 mM MgCl2). At the indicated times, the reaction was stopped by the 
addition of 0.2 M EDTA and heated at 98°C for 5 min. Samples were separated on 
denaturing 20% PAGE containing 1X TBE and 4 M urea. The gels were imaged using 
Fujifilm FLA-7000 phosphorimager (GE) and analyzed for the appearance of truncated 
32P-labeled products. The intensity of the radiolabeled nucleotides was quantified using 







3.5.8 DRaCALA measurement of dissociation constants  
 To measure Kd, serial dilutions of purified His10-MBP-Orn, His10-MBP Orn 
mutants, or untagged Orn were mixed with radiolabeled nucleotides in binding buffer 
10 mM Tris, pH 8, 100 mM NaCl, 5 mM CaCl2). Aliquots were applied to 
nitrocellulose sheets, dried, imaged and Kd values were calculated as described 
previously (226, 238). 
 
3.5.9 Preparation of P. aeruginosa whole cell lysates 
 Overnight cultures of P. aeruginosa PA14 WT, ∆orn, or complemented strains 
were sub-cultured into fresh media with antibiotic and 1 mM IPTG, grown at 37°C with 
shaking to OD600 ~ 2.5.All bacterial samples were collected by centrifugation and 
resuspended in 1/10 volume of buffer comprised of 100 mM Tris, pH 8, 100 mM NaCl. 
This was further supplemented with 25 mg/mL lysozyme, 10 mg/mL DNase, and 1 
mM PMSF and stored at -80°C. 
 
3.5.10 Aggregation assay 
 A colony of each strain of P. aeruginosa grown on LB agar plates supplemented 
with 50 mg/mL carbenicillin was inoculated into borosilicate glass tubes containing 2.5 
mL of LB supplemented with 0.1 mM IPTG. The cultures were placed in a fly-wheel 
in a 37°C incubator to spin for 18 ~ 22 hours. Culture tubes were allowed to settle at 







Chapter 4: Bacillus subtilis NrnA and NrnB Selectively Target 
Short RNA Oligonucleotides, But Differ in Their Substrate 
Preferences 
 
4.1 Copyright Notice 
 In this chapter, Figure 18 and Table 4 were originally published by Journal of 
Bacteriology: Orr MW, Weiss CA, Severin GB, Turdiev H, Kim SK, Turdiev A, Liu 
K, Tu BP, Waters CM, Winkler WC, Lee VT. (2018). A Subset of Exoribonucleases 
Serve as Degradative Enzymes for pGpG in c-di-GMP Signaling. 200: (24). e00300-
18. 
   
 
4.2 Introduction 
 The goal to identify enzymes in other phyla that could complement a 
conditional E. coli orn mutant and thereby participate in the terminal steps of RNA 
degradation led to the discovery of two RNases encoded by B. subtilis: NrnA and NrnB. 
The nrnA and nrnB genes appeared to complement the growth phenotype equally well, 
suggesting that B. subtilis encodes for more than one RNase that can restore the growth 
defect elicited by the conditional E. coli orn mutant (120, 121). From this, it was 
assumed that NrnA and NrnB are likely to behave in a redundant manner to cleave 
oligoribonucleotides. While the complementation experiment suggested that NrnA and 
NrnB are fully redundant, several other studies hinted that NrnA and NrnB may exhibit 





 NrnA and NrnB both belong to the DHH family of proteins. This superfamily 
consists of enzymes that exhibit DNA or RNA phosphodiesterase activity and that 
together encompass a broad range of substrate specificities (239). DHH family proteins 
can be found in higher organisms, such as the model organisms Drosophila and S. 
cerevisiae, as well as many bacteria. Proteins in this family have a conserved N-
terminal domain that is largely responsible for their inclusion in the DHH superfamily. 
The N-terminal domain comprises four distinct sequence motifs, each comprising a 
conserved aspartate residue (Figure 17). The third motif comprises the conserved 
residues DHH, for which the family is named (Pfam PF01368). In contrast, sequences 
of the C-terminal domain have been found to vary among family members. For 
example, only certain proteins within the DHH superfamily have an associated C-
terminal DHHA1 (DHH-associated domain 1, Pfam PF02272) domain. This domain is 
characterized by a conserved pair of glycine residues (Figure 17). The DHHA1 
subfamily of DHH proteins includes proteins of diverse functions, such as NrnA, c-di-
AMP phosphodiesterase GdpP, alanyl-tRNA synthetase (AlaRS), and RecJ (240–242). 
RecJ is a single-strand 5’-3’ DNase involved in DNA repair. Sequence alignment 
(ClustalW) between B. subtilis NrnA and NrnB shows that they each comprise the 
DHH and GG residues characteristic of the DHH/DHHA1 family. Interestingly, 
homology between NrnA and NrnB does not span the full-length sequences of each 
protein. Rather, NrnB appears to exhibit a unique C terminus that is absent from NrnA, 
suggesting it might be more distantly related to NrnB than current literature would 
indicate. It is therefore possible that the differences in protein sequence between NrnA 
















Figure 17. Alignment of NrnABs and NrnBBs. Protein sequences of B. subtilis NrnA and NrnB 
were aligned by ClustalW. Four motifs with conserved aspartate residues make up the DHH 
domain. The aspartate residues of each motif are in red. Other residues of NrnA that are 
putatively involved in catalysis are also in red. The DHH domain is shown in a red box, along 
with the DHHA1 motif. The DHHA1 motif is characterized by a pair of glycine residues. NrnB 
















































It has also been suggested that, in addition to cleaving oligoribonucleotides, NrnA has 
an additional role in sulfur metabolism. The nucleotide 3’-phosphoadenosine 5’-
phosphate (pAp) is generated during sulfur assimilation. NrnA was reported to 
dephosphorylate pAp to AMP in vitro, a function reminiscent of CysQ, the pAp 
phosphatase in E. coli (120). However, direct biochemical evidence to support this 
claim has not yet been published. Instead, support for an interaction between pAp and 
NrnA stemmed primarily from a screen for proteins that associated with pAp-agarose-
beads, which appeared to enrich NrnA in a pAp-dependent manner. NrnA was also 
shown to complement an E. coli cysQ mutant, which is auxotrophic for cysteine; in this 
strain, expression of nrnA restored cysteine prototrophy. These data together provide 
compelling evidence that suggests NrnA might act as a pAp phosphatase in vivo. 
Similarly, a B. subtilis nrnA mutant exhibited a slower growth rate in the absence of 
cysteine. However, this reduction in growth rate was mild overall, suggesting that there 
could be an additional enzyme that functions as a pAp phosphatase in B. subtilis. Yet, 
interestingly, NrnB is not thought to fulfill this role. It has been reported that NrnB was 
not able to complement the E. coli cysQ mutant (although the authors report this 
observation as data not shown) (121). Therefore, while both nrnA and nrnB can 
complement a conditional E. coli orn mutant, only NrnA is hypothesized to 
complement an E. coli cysQ mutant, suggesting that only NrnA can dephosphorylate 
pAp in addition to its presumed role as an exoribonuclease. Overall, these data provide 
support to the hypothesis that NrnA and NrnB exhibit fundamental differences from 





 Biochemical analyses of NrnA and NrnB in vitro have also produced 
controversial reports. While published experiments suggested that NrnA and NrnB are 
both 3’-5’ exoribonucleases, they also suggested that these enzymes have different but 
overlapping substrate specificities. In these experiments, NrnA and NrnB were purified 
and incubated with different RNA oligos that had been labeled with the Cy5 
fluorophore at their 5’ terminus (121). Purified recombinant NrnA and NrnB were both 
able to degrade 5’Cy5-CCCCC into shorter RNAs, as resolved by urea-denaturing 22% 
polyacrylamide gel electrophoresis. However, 3-mers were never observed as a 
reaction intermediate in the NrnA cleavage reaction, suggesting that NrnA 
preferentially cleaves 3-mers. Furthermore, when both 5’Cy5-CCCCC and 5’Cy5-CCC 
were each subjected to cleavage by NrnA, processing of the 3-mer to 2-mer appeared 
to be faster than degradation of the 5-mer. In contrast, NrnB did not show a preference 
for RNAs shorter than 5 nucleotides. It was also observed that NrnB was less active on 
3-mers than on 5-mers. From this, it is presumed that NrnA and NrnB both cleave short 
RNAs up to 5 nucleotides in length, but that NrnA might exhibit a preference for 3-
mers while NrnB is more active than NrnA against 5-mers. A 3-mer 
deoxyribonucleotide was also tested against NrnA and NrnB and, intriguingly, they 
were both reported to be capable of fully processing it; however, this data was 
regretfully not actually presented in the publication and was instead referred to as ‘data 
not shown’. In addition to short RNAs, a 5’ 33P-labeled 24-mer was also tested for 
degradation by NrnA and NrnB. It was determined that NrnB had “mild activity” 
against 24-mers, and that this activity was considerably less than the activity observed 





tested for cleavage of the 24-mer; cleavage by the mutant protein was not observed 
(data not shown). It should be noted however, that cleavage of 5’Cy5-CCCCC by this 
mutant was still detectable but reduced as compared to the wild-type protein. In 
contrast, degradation of 24-mer by NrnA was not observed in this study. However, 
more recent studies of NrnA suggested that NrnA is in fact bidirectional, preferentially 
cleaving longer RNA substrates from the 5’ end and shorter RNA substrates from the 
3’ terminus (243). In potential agreement with this hypothesis, NrnA and the 5’-3’ 
exonuclease RecJ exhibit significant similarity in overall sequence and structural 
homology. Although 3’-5’ activity was confirmed for a 3-mer RNA, cleavage of a 3’-
32P-labeled 12-mer RNA, was observed from the 5’ direction. It should be noted that 
this was over the course of four hours, whereas cleavage of 3-mers (from the 3’ 
terminus) could be observed in minutes. Confounding straightforward interpretation of 
these data, however, was the inclusion of 10-fold excess enzyme in the reactions that 
targeted longer RNA substrates as compared to the shorter ones. Catalytic site mutant 
variants of NrnA completely abrogated 3’-5’ exonuclease activity, but not the 5’-3’ 
cleavage activity. While the evidence is currently inconclusive, if NrnA is indeed 
bidirectional, it would represent a rare instance of dual polarity for an RNase enzyme.   
 Our recent re-evaluation of Orn shows that Orn functions not as an 
oligoribonuclease, as previously believed, but instead functions as a specialized 
ribonuclease of diribonucleotide substrates. This re-evaluation was based on 
considerations of equilibrium binding constants, physiologically relevant 
concentrations of enzyme, and a combination of in vivo, biochemical, and structural 





RNAs containing fluorophore probes, specifically revealed the true substrate 
specificity for Orn that had remained hidden from prior studies, where bulky 
fluorophore moieties were likely to have interfered with the substrate binding pocket. 
Given that NrnA and NrnB can complement Orn deletion mutants, the simplest 
hypothesis is that they share exactly overlapping substrate requirements and overall 
cellular roles. But as summarized above, the available data on NrnA and NrnB paint a 
more confusing picture of what exactly these proteins are likely to be doing inside cells. 
Simply put, it is currently unclear whether NrnA and NrnB are ‘diribonucleotidases’ 
(akin to Orn), whether they are RNases that specialize in “short” RNA substrates, 
whether they are RNases that process both “long” and “short” substrates, or whether 
they are nucleases that process both RNA and DNA substrates. Moreover, it is even 
unclear whether they act only in one direction, as do most RNase enzymes, or exhibit 
bidirectional abilities. Therefore, in this analysis, we wanted to conduct a preliminary 
study to assess NrnA and NrnB catalysis under uniform conditions and using the same 
rigorous analyses that we applied to Orn. From our analysis, we expect to determine 




4.3.1 In B. subtilis, ∆nrnAB leads to elevated levels of c-di-GMP and pGpG 
 The ability of B. subtilis nrnA and nrnB to complement the E. coli and P. 





cleavage in B. subtilis in a manner that is analogous to Orn function. If analogous, not 
only should intracellular pGpG levels accumulate, but also c-di-GMP levels, due to 
feedback inhibition of PDE-As by pGpG (113, 118). Thus, we constructed a B. subtilis 
∆nrnA ∆nrnB double mutant. This mutant, as well as wild-type were consequently 
assayed for c-di-GMP levels using the fluorescent c-di-GMP riboswitch reporter 
previously described in Chapter 2. As a control, a constitutively active yfp reporter was 
used (Figure 18A). As expected, the control reporter showed no differences in 
fluorescence between the wild-type and the ΔnrnA ΔnrnB double mutant, with the same 
histogram distribution of fluorescence intensity in the two strains (Figure 18B, D). As 
discussed previously, assessment of the c-di-GMP reporter in a wild-type B. subtilis 
population shows a bimodal distribution of fluorescence, indicating that some sub-
populations of B. subtilis within a multicellular community exhibit higher levels 
intracellular c-di-GMP relative to other subpopulations. Higher intracellular c-di-GMP 
levels are expected to bind to the c-di-GMP riboswitch within the lchAA leader to 
promote formation of a transcription terminator, thereby halting expression of yfp. The 
ΔnrnA ΔnrnB mutant exhibited very low fluorescence compared to the wild-type, 
indicating that c-di-GMP levels are indeed higher in this strain (Figure 18C, E). 
Correspondingly, the accumulation of c-di-GMP in the ΔnrnA ΔnrnB mutant is likely 
to be due to pGpG accumulation that competitively inhibits the linearization of c-di-
GMP. As an independent measure of c-di-GMP, intracellular c-di-GMP and pGpG 
were quantified by LC-MS/MS in B. subtilis wild-type and ΔnrnA ΔnrnB mutant 
strains (Table 4). This revealed that pGpG was undetectable in wild-type cells, but 








Figure 18. Detection of c-di-GMP levels in B. subtilis ∆nrnA ∆nrnB. (A) Schematic for YFP 
production by Pconst-yfp and Pconst-lchAA UTR-yfp in response to high and low c-di-GMP. 
Representative images of fluorescence from (B) Pconst-yfp or (C) Pconst-lchAA UTR-yfp in either 
B. subtilis 168 wild-type (WT) or ΔnrnA ΔnrnB. Histograms of the quantification of average 
fluorescence intensity of B. subtilis 168 wild type and ΔnrnA ΔnrnB with (D) Pconst-yfp or (E) 
















Table 4. Intracellular concentrations of pGpG and c-di-GMP in B. subtilis WT and  
 ∆nrnA ∆nrnB strains 













Substance Daughter ion WT 168 ∆nrnA ∆nrnB Fold Change 
(mutant/WT) 
pGpG 1 ND 1.8 -/+0.6 µM NA 
pGpG 2 ND 1.8 -/+0.4 µM NA 
c-di-GMP 1 0.8 -/+ 0.2 µM 2.4 -/+0.5 µM 3.0 





Furthermore, 1 µM c-di-GMP was measured within wild-type B. subtilis, as compared 
to 3 µM c-di-GMP for the ∆nrnA ∆nrnB double mutant. From these data we conclude 
that the ∆nrnA ∆nrnB mutations cause an increase in both c-di-GMP and pGpG, but 
that the elevated pGpG levels are still not high enough to trigger the lchAA riboswitch. 
This indicates that product inhibition of c-di-GMP hydrolysis by elevated pGpG occurs 
in B. subtilis as it does in P. aeruginosa, suggesting it may be a widespread 
phenomenon. In summary, these results indicate that NrnA and NrnB are the enzymes 
primarily responsible for the degradation of pGpG in B. subtilis. 
 
4.3.2 Protocol optimization to generate B. subtilis lysates for RNA cleavage  
 In our previous studies, the ability to visualize RNA cleavage patterns in P. 
aeruginosa bacterial lysates by gel electrophoresis allowed us to determine that Orn is 
the only diribonucleotidase in that organism. Thus, we wanted to use a similar method 
for the assessment of B. subtilis NrnA and NrnB. For these studies we chose to visualize 
cleavage of 1 µM 7-mer RNA (5’AAAAAGG). 1 µM of 5’-monophosphorylated 7-
mer was prepared with trace amounts of 32P end-labeled 7-mer and added to different 
preparations of lysates from several different B. subtilis strains. Reactions were allowed 
to proceed for up to two hours and aliquots of the cleavage reaction over time were 
stopped by the addition of 150 mM EDTA and urea. Reaction products were then 
resolved by urea-denaturing 20% PAGE. All reactions were conducted in the presence 
of 10 mM Tris pH 8.0 and 100 mM NaCl. 5 mM MgCl2  was added to promote catalysis. 
  In prior studies of Orn, P. aeruginosa cells were lysed with a mixture of 





three times (i.e., transferred repeatedly between -80˚C and room temperature). B. 
subtilis, however, is a Gram-positive organism with a thicker peptidoglycan layer. 
Therefore, B. subtilis cells were treated with 10X more lysozyme than is typically used 
for Gram-negative organisms. However, when wild-type B. subtilis 168 was treated 
with lysozyme, DNaseI, and PMSF alone, the corresponding lysates still showed no 
detectable cleavage of 7-mer RNA. Consequently, bead-beating methods were used to 
more rigorously lyse the Gram-positive cells. To determine the ideal amount of cells 
that would be needed for active lysates (i.e., sufficient to observe RNA cleavage 
activity), 1 mL, 5 mL, 10 mL, and 25 mL of cultures of B. subtilis 168 wild-type or 
∆nrnA ∆nrnB were harvested by centrifugation. These aliquots were pelleted and 
resuspended in 1 mL buffer, and subjected to bead beating. 1 µM radiolabeled 7-mer 
RNA was then incubated with aliquots of each resuspension and analyzed by 20% urea-
denaturing PAGE; the most optimal activity was observed from lysates prepared from 
10 mL of B. subtilis culture (Figure 19C). This determination was based on several 
observations. In reactions generated from 1 mL and 5 mL of culture, no cleavage 
activity whatsoever was observed, leading us to think that not enough cells were lysed 
to visualize RNase activity (Figure 19A, B). Furthermore, electrophoresis of the 
reactions failed to separate residual 32P-𝛾-ATP from AMP. These two species ran 
together with the solvent front. In support of this, cleavage of the 7-mer could be 
observed in the lysates generated from 10 mL and 25 mL B. subtilis culture (Figure 19 
C, D). Similar to what was observed in the 1-5 mL reactions, however, the 25 mL 
reactions failed to separate residual 32P-𝛾-ATP from AMP, for reasons that are not 








Figure 19. Absence of NrnA and NrnB leads to accumulation of 2-4mers in cell lysates. 
Degradation of 1µM AAAAAGG (mixed with 5’ 32P-labeled tracer) by whole cell lysates of 
B. subtilis wild-type and ∆nrnA ∆nrnB. Samples were stopped at the indicated time and 
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B. subtilis 168 wild-type or ∆nrnA ∆nrnB for our analyses of RNA cleavage. As 
expected, in 1 hour, a 7-mer RNA was cleaved to near completion for lysates prepared 
from wild-type cells (Figure 19C). In these reactions, intermediates of 6-mer, 5-mer, 4-
mer, and nucleoside monophosphate were obversable. Interestingly, 2-mer and 3-mer 
intermediates were not observed at all, and 4-mer intermediates seemed to be less 
abundant than 5-mer and 6-mer intermediates. Cleavage of the 7-mer was also possible 
in the absence of NrnA and NrnB, as determined by incubation of RNA in lysates 
prepared from ∆nrnA ∆nrnB cells. Intriguingly, in the ∆nrnA ∆nrnB lysates there was 
a distinct accumulation of 2-mer and 3-mer RNAs, and the levels of 4-mer were more 
abundant than in the wild-type lysates. In summary, analyses of RNA cleavage in 
lysates of B. subtilis suggested that 2-mers, 3-mers, and 4-mers accumulated in the 
absence of NrnA and NrnB.  
 
4.3.3 NrnA and NrnB have different substrate specificities 
 Our prior imaging and mass spectrometry studies suggested that pGpG levels 
accumulated upon depletion of NrnA and NrnB. This was supported by our analysis of 
RNA cleavage in cell lysates. However, the lysate data also suggested that 3-mers and 
4-mers accumulated in the absence of NrnA and NrnB as well. To fully understand the 
length preferences of NrnA and NrnB, recombinant affinity-tagged B. subtilis NrnA 
(NrnABs) and NrnB (NrnBBs) were purified to homogeneity and then tested for cleavage 
of RNA substrates. NrnABs and NrnBBs were incubated with 5’-32P-radiolabeled 
oligoribonucleotides of varying lengths at substrate concentrations that exceed enzyme 





products of these reactions were resolved by urea-denaturing 20% PAGE. Analysis of 
NrnABs showed that, as anticipated, it fully processed the dinucleotide pGpG in 10 
minutes (Figure 20A). Importantly, NrnABs showed very similar activity against the 3-
mer AGG within the same time frame. This provides direct evidence that 2-mers and 
3-mers are a preferred substrate of NrnABs. Similar to our prior studies, a dinucleotide 
intermediate was not observed. As with our assays on Orn activity, we interpret this 
observation to suggest that the rate of hydrolysis for 2-mers is faster than the time points 
that were chosen. Alternatively, these data could also be consistent with the pattern that 
would be observed if NrnABs was able to cleave the 3-mer from the 5’ end. In other 
words, if NrnABs removes nucleoside monophosphates from the 5’ terminus of a 3-mer 
oligonucleotide, it would be expected to result in accumulations of NMP and 
dinucleotide intermediates should be absent. Yet, the same pattern would be expected 
if dinucleotide substrates were simply processed at a much higher rate than 3-mer 
RNAs. Our current data cannot differentiate between these two possibilities. While 
some processing of a 4-mer was observed under these reaction conditions, the observed 
rate of cleavage appeared to be slower than that of the 3-mer or dinucleotide in the 
same amount of time (Figure 20B). And, similar to the reaction profile of the 3-mer 
substrate, intermediate RNA lengths were not observed; the only evidence for RNA 
cleavage was from a modest increase in nucleoside monophosphate levels. Similarly, 
NrnABs was unable to cleave longer substrates (i.e., from 5-mers to 7-mers. (Figure 
20A). These RNA cleavage patterns mirrored what was observed when a 7-mer was 









Figure 20. NrnABs and NrnBBs have different substrate preferences in vitro. RNA 
nucleotides two to seven residues in length (1 μM, containing the corresponding 32P-labeled 
RNA tracer) were each subjected to cleavage over time with 20 nM (A) NrnABs or (B) 
NrnBBs. Aliquots of each reaction were stopped at indicated time (mins), and assessed by 
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Interestingly, under the same reactions conditions as NrnABs, which fully processed all 
pGpG, NrnBBs cleaved only half (Figure 20B). Moreover, the overall reaction profiles 
differed dramatically between NrnABs and NrnBBs. RNAs that were 3-7 nucleotides in 
length were all fully processed within the same time frame when incubated with NrnBBs 
(Figure 20B). Cleavage of RNA was inversely correlated to the size of RNA substrate, 
where NrnBBs cleaved the 7-mer faster than the other substrates. Also, the NrnBBs 
cleavage reactions resulted in accumulation of shorter RNA intermediates (Figure 
20B). This contrasts strongly with the pattern for NrnABs, which was active against 2-
mer, 3-mer and 4-mer, but in all instances only ever produced an accumulation of 
nucleoside monophosphates. The production of degradation intermediates provided 
strong evidence that NrnBBs acts as a 3’-5’ exonuclease. Additionally, these data 
suggest that NrnBBs may prefer longer substrates than NrnABs. From these data, we 
conclude that NrnBBs is an exoribonuclease that acts from the 3’ terminus, and that it 
is not a dedicated dinucleotidase akin to Orn. Our data on NrnABs are less clear. Our 
data can be interpreted in several ways and cannot differentiate between several 
different models: (1) NrnABs is a dinucleotidase, (2) NrnABs removes 5’ residue(s) from 
short (between 2-4) RNAs, or (3) NrnABs removes 3’ residues from short RNAs but 
processes intermediates faster than the time points that were used in our pilot assays. 
While more work will need to be done to resolve the enzymatic preferences of NrnA, 
our pilot data conclusively show that NrnA and NrnB exhibit significant differences in 






4.3.4 NrnA and NrnB are expressed under different conditions 
 The apparent difference in cleavage activity of NrnABs and NrnBBs for pGpG 
made us consider what the physiological consequences of this might be in vivo. 
Previous imaging studies of the c-di-GMP-responsive riboswitch reporter showed that 
in the absence of both NrnABs and NrnBBs, intracellular c-di-GMP and pGpG levels 
accumulate. This result ultimately suggested that NrnABs and NrnBBs are required for 
pGpG turnover in B. subtilis. However, single deletions of each RNase were not 
analyzed. To determine the relative contributions of pGpG turnover from each RNase, 
c-di-GMP levels were assayed using the c-di-GMP-responsive riboswitch-yfp reporter 
in a B. subtilis wild-type, ∆nrnA, or ∆nrnB background, in a manner described in 
Chapter 2. As expected, the constitutive yfp control reporter showed mild to no 
differences in fluorescence between the wild-type and the single ΔnrnA or ΔnrnB 
mutants (Figure 21A, B). This was exemplified by the similar histogram distributions 
of fluorescence intensity among the three strains (Figure 21A, B). Also, in agreement 
with our prior observations, assessment of the c-di-GMP reporter in a wild-type B. 
subtilis population showed a bimodal distribution of fluorescence, indicating 
differences in intracellular c-di-GMP among the subpopulations (Figure 21C, D). In 
the ΔnrnA background, the riboswitch reporter exhibited very low fluorescence 
compared to the wild-type, indicating that c-di-GMP levels, and, consequently, pGpG 
levels, are higher in this strain (Figure 21C, D). This observation is consistent with a 
role in turnover of pGpG for NrnABs. It should be noted that although diminished 
fluorescence was observed in the ∆nrnA strain, the fluorescence intensity does not 







Figure 21. In B. subtilis c-di-GMP levels change in response to ∆nrnA during vegetative 
growth. Representative fluorescence microscopy images of YFP production from (A) Pconst-
yfp or (C) Pconst-lchAA UTR-yfp in B. subtilis 168 wild-type (WT), ΔnrnA, or ΔnrnB strains. 
Histograms of the quantification of average fluorescence intensity of B. subtilis 168 wild type,  
ΔnrnA, and ΔnrnB with (B) Pconst-yfp or (D) Pconst-lchAA UTR-yfp cells (n~300). 
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these two experimental conditions cannot be directly compared, as different exposure 
conditions were used between experiments. Interestingly, a bimodal distribution of 
fluorescence was observed from the riboswitch-yfp reporter in the ∆nrnB strain, similar 
to wild-type (Figure 21C, D). This suggests that if NrnBBs does cleave pGpG during 
late exponential phase of growth (OD600 ~1.0), accumulation of the dinucleotide in the 
absence of NrnBBs is not enough to promote feedback inhibition of enzymes that 
linearize c-di-GMP. This result was also supported by treatment of pGpG with B. 
subtilis lysates from single ∆nrnA or ∆nrnB mutants harvested at late exponential 
phase. 1 µM pGpG was mixed with trace amounts of 5’-32P end-labeled pGpG and 
subjected to cleavage over the course of two hours in the presence of 5 mM MgCl2. 
While pGpG was readily degraded by wild-type lysates and ∆nrnB lysates in a similar 
manner, cleavage of pGpG was not observed in the ∆nrnA strain (Figure 22). Together 
these data suggest that NrnABs is the primary RNase responsible for cleaving pGpG 
during late exponential phase. 
 The observation that NrnBBs either does not cleave pGpG at all or does not do 
this during late exponential phase of growth, led us to consider when in B. subtilis 
development nrnA and nrnB are expressed. Recently, a large-scale study was 
undertaken to systematically and quantitatively explore transcriptional changes that 
occur in B. subtilis in response to over 100 nutritional changes and chemical stresses 
(179). The data generated from this large study is accessible on a freely available 
database, B. subtilis Expression Data Browser, for researchers 
(http://genome.jouy.inra.fr/cgi-bin/seb/index.py). Expression patterns of all B. subtilis 















Figure 22. Absence of NrnA alone results in loss of pGpG cleavage activity for B. subtilis 
during vegetative growth. 1 µM pGpG (containing the corresponding 5’ 32P-labeled RNA 
tracer) was subjected to cleavage by lysates of B. subtilis 168 wild-type (WT), ∆nrnA, ∆nrnB, 
or ∆nrnAB that had been grown to late log (OD600 ~ 1.0). Reactions were stopped at indicated 


















 Based on this study, there were several different conditions that induced the 
highest expression of nrnA (Figure 23A). These included induction of competence 
(C90), treatment with the oxidative drug diamide (dia5, dia15), exponential growth in 
low and high phosphate defined medium (LPh, HPh), during growth in a synthetic 
minimal medium (Belitsky Minimal Medium) prior to stress (BMM), and finally, 
during germination from sporulation (G135, G180). The general trends suggests its 
expression occurs during exponential phase of growth in diverse media. This is 
consistent with our microscopy data that suggested c-di-GMP and pGpG levels 
accumulate at OD600 ~ 1.0 in MSgg medium when nrnA is removed.  Intriguingly, 
however, the expression conditions for nrnB were highest throughout development of 
sporulation (Figure 23B). Cells were grown in CH medium at 37°C and sporulation 
was induced by resuspension in warm sporulation medium as described by Sterlini and 
Mandelstam (244).  Following induction of sporulation, samples were harvested at 
hourly intervals, and nrnB expression levels were highest 4-8 hours into sporulation 
(S4-S8). These time points are concurrent with the activation of specific transcription 
factors in the forespore and mother cell that allow for compartmentalized gene 
expression. This compartment specific gene expression program directs proper 
formation of the spore coat and cortex prior to spore release. The highest expression of 
nrnB was also observed during stationary phase (LBGstat), as well as after 24 hours of 
incubation in MSgg medium to induce biofilm formation (BT). It should be noted that 
many studies have shown that spores are spatially organized within a B. subtilis biofilm 
community (135, 140). Therefore, the currently available transcriptomic data suggests 






Figure 23. Transcriptomic data reveals when B. subtilis nrnA and nrnB are expressed.  











data. The deletion of nrnB had no observed effect on c-di-GMP or pGpG levels in late-
exponential phase, as measured by our fluorescent c-di-GMP riboswitch reporter. If 
nrnB is expressed during sporulation, then we would not expect to see activity during 
the phase of growth that we assessed. Therefore, it is possible that nrnB is a sporulation-
specific exoribonuclease. If true, this would be the first instance of an RNase that plays 





 At best, the published literature that is currently available poses a remarkably 
confusing picture of the functions of NrnA and NrnB. As discussed in the Introduction 
of this chapter, initial characterization of NrnA and NrnB suggested that they are 
generally involved in degradation of short RNAs as 3’-5’ exonucleases and are fully 
redundant with one another (120, 121). However, subsequent studies also propose that 
NrnA might act as a 5’-3’ exonuclease as well as a 3’-5’ exonuclease (243). Therefore, 
in this chapter, our goal was to conduct an initial survey using a common set of reaction 
conditions to determine whether NrnA and NrnB exhibited differences in their substrate 
preferences. From our data we conclude that NrnA and NrnB clearly exhibit substrate 
differences and are expressed under entirely different physiological conditions; 
therefore, they are not redundant proteins, and likely serve different functions in B. 
subtilis. 
 While the original complementation experiment that identified NrnABs and 





NrnB, it also exemplifies the challenges in utilizing a single term (i.e., “nanoRNase”) 
to refer to degradation of short RNAs.  The term “nanoRNA” was coined to distinguish 
extremely short oligoribonucleotides 2-7 nucleotides in length from longer 
microRNAs, which are presumably around 20-30 nucleotides in length. Subsequently, 
enzymes such as Orn, NrnA, NrnB, and NrnC are all defined as general “nanoRNases” 
capable of processing “nanoRNA” of any length shorter than 7 nucleotides. A problem 
with this term is that it could lead to inaccurate assumptions about the biochemistry 
and functional roles of these RNase enzymes if they exhibit substrate differences from 
one another. Indeed, the work described in this dissertation clearly demonstrates, 
however, that Orn is not a “nanoRNase” at all, but is in fact a dedicated 
diribonucleotidase in cells. This discovery indicates that, by reducing cellular 
diribonucleotides, this activity clears a very specific terminal bottleneck in global RNA 
degradation.  This discovery also exemplifies the danger in introducing a term that 
poorly defines the substrate specificities of multiple enzymes that do not share common 
evolutionary history. The immediate goal of our preliminary experiments was to 
identify if under standardized conditions, NrnABs and NrnBBs had different substrate 
specificities. Our preliminary observations suggest that this may very well be the case. 
NrnBBs seemed to cleave 5-7 nucleotide-long RNAs more readily than NrnABs. 
Although NrnBBs has the biochemical capacity to cleave the dinucleotide pGpG as well 
as 3-mers and 4-mers, NrnBBs may not even be expressed during exponential growth. 
Instead, NrnB may have a specific role in clearing short RNAs during the 
developmental program of endospore formation, and this should be explored. We 





roles. Therefore, defining NrnA and NrnB as general “nanoRNases” precludes them 
from having different substrate specificities, and only serves to add confusion in 
determining true functions of these RNases in the cell. We argue that this term should 
be removed from future characterizations of RNases.  
 One of the earliest pieces of evidence that Orn shows substrate specificity for 
diribonucleotides came from equilibrium binding constants of purified OrnVc and 32P-
5’ end labeled RNAs two to seven nucleotides in length. A similar approach should be 
carried out with purified NrnABs and NrnBBs. This may help identify which RNA 
substrates NrnABs and NrnBBs are most likely to process. RNA cleavage assays with 
different concentrations of each enzyme may also determine how the substrate 
specificity of NrnA and NrnB changes directly in response to altered enzyme 
concentrations. After all, in our investigations of Orn, RNA substrates were incubated 
with OrnVc at different molar ratios to show that while Orn specifically prefers 
dinucleotides, Orn has the ability to cleave substrates longer than a dinucleotide. These 
assays demonstrate how biochemical studies alone are susceptible to many variables, 
such as enzyme concentration, substrate concentration, temperature, and time. Our data 
begins to address that a systematic analysis, where reaction conditions and products are 
all uniform in all assays, can reveal unequivocally the substrate preferences of NrnA 
and NrnB and how they compare to Orn. Finally, further in vivo characterization of 
these enzymes will determine whether or not they are differentially regulated.  
 Cleavage of RNAs 2-4 nucleotides in length by purified NrnA resulted in 
visualization of nucleoside monophosphates. However, intermediate species were not 





if NrnA were removing the terminal phosphate from the 5’ direction. Consequently, 
this remains an important open question that will require more definitive experiments. 
While our data do not conclusively resolve NrnA’s activities, they do demonstrate that 
NrnA exhibits significant differences from NrnB and should not be considered 
redundant proteins. Therefore, our work in this chapter establishes the questions that 
should be asked next in trying to understand the molecular function(s) of the NrnA and 
NrnB proteins.   
 
 
4.5 Materials and Methods 
4.5.1 Bacterial strains, plasmids, and growth conditions 
 All B. subtilis strains in this study are derived from 168 (unless otherwise 
noted). Strains were grown at 37˚C on Lysogeny Broth (LB) plates supplemented with 
1.5% Bacto Agar and when appropriate, with final concentrations of the following 
antibiotics: 5 μg/mL chloramphenicol, and 1 μg/mL erythromycin added alongside 25 
μg/mL lincomycin (mls). Integration at the amyE locus was performed with plasmids 
derived from pJG019 (GenBank: KX499653.1), To construct pRSL_F4, the lchAA 
leader sequence was synthesized (GenScript) and subcloned into the HindIII restriction 
site of pJG019.  To make markerless deletions of ∆nrnA and ∆nrnB, strains harboring 
an erythromycin-resistance cassette inserted in loci BSU29250 (nrnA), and BSU18200 
(nrnB), were obtained from the BKE collection (BGSC).  Markerless deletions were 





Removal of the erythromycin-resistance cassette was verified by Sanger sequencing. 
Transformation of 168 was performed using a previously described protocol (216).  
. 
 
4.5.2 Fluorescence microscopy and quantification 
 The B. subtilis 168 wild-type (WT) and the ΔnrnA ΔnrnB and mutant-derived 
reporter strains were grown at 37˚C on LB plates supplemented with 1.5% Bacto agar 
and 5 µg/ml chloramphenicol, when appropriate. Single colonies were used to inoculate 
liquid minimal salts glycerol glutamate (MSgg) medium (40) and were grown at 37˚C 
with shaking overnight. The following day, cultures of each strain were inoculated 1:50 
on fresh medium and grown at 37˚C shaking until reaching an optical density at 600 
nm (OD600) of 1.0. Aliquots of these cultures were placed on 1.5% low-melting-point 
agarose MSgg pads and allowed to dry for 10 min. The agarose pads were inverted 
onto a glass-bottom dish (Willco Wells). Cells were imaged at room temperature using 
a Zeiss Axio Observer Z1 inverted fluorescence microscope, equipped with a Rolera 
EM-C2 electron-multiplying charge-coupled (EMCC) camera and an environmental 
chamber. Fluorescence intensity per cell was quantified using the Oufti analysis 
software (41). Images were analyzed and adjusted with the Fiji software (42) 
 
4.5.3 Metabolite extraction of c-di-GMP and pGpG in B. subtilis.  
 Three independent replicates of B. subtilis 168 WT and ΔnrnA ΔnrnB mutant 
strains were grown overnight in liquid MSgg medium (40) with shaking at 37˚C. The 
following day, cultures of each strain were inoculated 1:50 and grown with shaking at 





was described previously (45). Five-milliliter cultures were passed through 0.2-µm 
nylon filters (EMD Millipore). Metabolism was quenched, and metabolites were 
extracted by inverting the filters into petri dishes that contained 1.5 mL prechilled 
extraction solvent composed of 40:40:20 acetonitrile-methanol-water. Dishes were 
placed on dry ice for 15 minutes before the wash was collected in microcentrifuge tubes 
and allowed to spin at maximum speed for 5 minutes at 4˚C. The supernatant was then 
transferred to new microcentrifuge tubes and placed in a vacuum centrifuge until the 
metabolite extracts were dry.  
 
4.5.4 Detection and quantification of c-di-GMP and pGpG in B. subtilis 
 The detection of c-di-GMP by LC-MS/MS was described previously (46). 
Briefly, bacterial extract was resuspended in solvent A (10 mM tributylamine in water 
[pH 5.0]) and centrifuged twice to remove insoluble particles. Metabolites were then 
separated on a Synergi Fusion-RP column (4-µm particle size, 80-Å pore size, 150 mm 
by 2 mm; Phenomenex) using a Shimadzu high-performance liquid chromatography 
machine and simultaneously analyzed by a triple quadrupole mass spectrometer (3200 
QTrap; Ab Sciex). The total run time was 20 min, at a binary flow rate of 0.5 ml∙min-
1, with 10 mM tributylamine in water (pH 5.0) as solvent A and 100% methanol as 
solvent B. The following gradient was performed: 0.01 min, 0% B; 4 min, 0% B; 11 
min, 50% B; 13 min, 100% B; 15 min, 100% B; 16 min, 0% B; and 20 min, 0% B. c-
di-GMP and pGpG were detected by multiple-reaction monitoring (MRM) under 
negative mode using the ion pairs 689/79 and 689/344 (c-di-GMP) and 707/79 and 





(version 1.6.2) by calculating the total peak area and were normalized by total ion 
current (TIC). Authentic c-di-GMP and pGpG standards were injected and analyzed 
alongside the samples. 
 
4.5.5 Labeling of RNAs 
 5’ un-phosphorylated RNAs were purchased from TriLink Biotechnologies or 
Sigma. Each RNA was subjected to radioactive end-labeling or non-radioactive 
phosphorylation by T4 Polynucleotide Kinase (New England Biolabs). Each RNA was 
subjected to phosphorylation with equimolar concentrations of either 32P-gamma	ATP 
or ATP, T4 PNK, and 1X T4 PNK Reaction Buffer. Reactions comprising a final 
concentration of either 0.5 µM radiolabeled RNA or 2.0 µM phosphorylated RNA were 
incubated at 37°C for 40 min, followed by heat inactivation of T4 PNK at 65°C for 20 
mins.	
 
4.5.6 Protein expression and purification for biochemical assays 
 E. coli T7Iq strains harboring expression vector pVL847 expressing an His10-
MBP-NrnA and His10-MBP-NrnB from B. subtilis were grown overnight, subcultured 
in LB M9 fresh media supplemented with 15 mg/ml gentamicin and grown to 
approximately OD600~0.5 at 30°C. Expression was induced with 1 mM IPTG for 4 
hours. Induced bacteria were collected by centrifugation and resuspended in 10 mM 
Tris, pH 8, 100 mM NaCl, and 25 mM imidazole. After addition of 10 mg/mL DNase, 
25 mg/mL lysozyme, and 1 mM PMSF, bacteria were lysed by sonication. Insoluble 





separation over a Ni-NTA column. Purified proteins were pooled and dialyzed for 1 
hour and overnight against 10 mM Tris, pH 8, 100 mM NaCl, aliquoted, and flash 
frozen with liquid nitrogen and stored at -80°C. 
  
4.5.7 Purified NrnABs and NrnBBs cleavage reactions 
 Phosphorylated RNA (1.0 µM), including trace amounts of radiolabeled 
substrate, was subjected to cleavage by purified 20 nM His10-MBP-NrnABs or His10-
MBP-NrnBBs at room temperature. These reactions were in the presence of 10 mM Tris, 
pH 8.0, 100 mM NaCl, and 5 mM MgCl2. At the appropriate times, aliquots of the 
reaction were removed and quenched in the presence of 150 mM EDTA on ice and heat 
inactivated at 95°C for 5 min. Samples were separated on denaturing 20% PAGE 
containing 1X TBE and 4 M urea. The gels were imaged using Fujifilm FLA-7000 
phosphorimager (GE) and analyzed for the appearance of truncated 32P-labeled 
products. The intensity of the radiolabeled nucleotides was quantified using Fujifilm 











Chapter 5:  Conclusions and Perspectives 
 
5.1 A Broadening Role for c-di-GMP Regulation in Bacteria 
 The second messenger molecule c-di-GMP is a widely used regulator in the 
switching of lifestyle choices among bacteria. In general, high levels of c-di-GMP 
promote biofilm formation and cell cycle control, while low levels are associated with 
motility and virulence (16). This theme is largely maintained for B. subtilis, where a 
high level of c-di-GMP is correlated with production of an unknown biofilm EPS and 
reduced motility. An increasing number of studies suggest a broadening role for c-di-
GMP signaling in Gram-positive bacteria, however. Studies on Bacillus cereus group 
organisms, Clostridioides difficile, and Streptomyces coelicolor have revealed a link 
between c-di-GMP metabolism and spore formation, which is a developmental 
program almost exclusive to the three genera (160). As mentioned earlier in this 
dissertation, there is an ortholog of B. subtilis YkuI in the B. cereus bacterial group, 
named CdgJ, that has been implicated in the regulation of biofilm formation and 
sporulation (181). The high similarity in protein sequences between YkuI and CdgJ 
allows for the possibility that YkuI might also exhibit a similar role in B. subtilis, 
although it has yet to be explored. Sporulation is also affected by c-di-GMP in S. 
coelicolor. Overexpression of DGCs cdgA or cdgB, or deletion of PDEs rmdA or rmdB 
led to an increase in intracellular c-di-GMP and inhibition of sporulation (245, 246). 
Studies on S. coelicolor have also revealed the only c-di-GMP-sensing, transcriptional 





c-di-GMP, BldD represses sporulation genes during vegetative growth. 
Correspondingly, deletion of BldD leads to accelerated sporulation. These phenotypes 
were inhibited through overexpression of the diguanylate cyclases cdgA and cdgB, 
which are also direct targets of BldD (245, 246). C-di-GMP was also shown to repress 
expression of antibiotic synthesis genes via BldD. The presence of a c-di-GMP 
riboswitch upstream of the B. licheniformis lchAA secondary metabolite biosynthesis 
gene cluster suggests that secondary metabolites might be under direct regulatory 
influence by c-di-GMP in some Bacillus species and other Gram-positive organisms. 
If confirmed, this would represent a new functional category of genes regulated by c-
di-GMP in bacteria. In summary, while B. subtilis has served as a general model 
organism for many Gram-positive bacteria, emerging studies in B. subtilis and other 
organisms have revealed an unambiguous role for c-di-GMP signaling during 
differentiation pathways such as motility and biofilm formation (160, 174, 181, 249–
255).  However, a theme is emerging that c-di-GMP signaling may affect secondary 
metabolite production, competence, and sporulation. Our own work discussed in 
Chapter 2 suggests that c-di-GMP levels are markedly different between competent and 
sporulating cells. Therefore, B. subtilis and other Gram-positive organisms utilize c-di-
GMP signaling to regulate unique cell development pathways. 
 The creation of a fluorescent reporter based on a c-di-GMP-responsive 
riboswitch provides an accessible tool for elucidating the outcomes of c-di-GMP 
regulation in specific sub-populations of bacteria. For example, our reporter provided 
data on tricellular c-di-GMP levels during competence and sporulation. These 





regulation in this organism. Moreover, many different riboswitches can be used as 
fluorescent tools for measuring intracellular metabolite dynamics. 
 The molecular details of c-di-GMP targets in B. subtilis also require further 
exploration. Additional c-di-GMP effectors and their targets likely have yet to be 
identified. Several high-throughput methods have been recently developed for 
assessing c-di-GMP-binding partners (226, 256–259). It is possible that the use of one 
of these methods to target B. subtilis c-di-GMP interactions could potentially reveal 
new c-di-GMP binding partners in the future. Analysis of transcriptomic changes that 
occur in response to changes in c-di-GMP should also reveal yet undiscovered 
regulatory targets of c-di-GMP under different physiological conditions.  
 
5.2 Differences in RNA Recycling Mechanisms Among Bacteria 
 C-di-GMP signaling is terminated when phosphodiesterases (PDE-As) cleave 
c-di-GMP into the linear diribonucleotide pGpG (70, 73). Different classes of 
phosphodiesterases have been shown to also linearize c-di-AMP into pApA (124). 
While the phosphodiesterases involved in cGAMP and cyclic UMP-AMP signaling 
have yet to be discovered, these cyclic nucleotides  are expected  to be linearized into 
their respective dinucleotide constituents in a similar fashion. Cyclic dinucleotide 
signaling, therefore, represents one pathway in which diribonucleotides are generated 
in bacteria. Diribonucleotides are expected to be produced from other cellular 
mechanisms as well. For example, short RNAs 2-15 nucleotides in length are also 
generated from multiple rounds of abortive transcription initiation by RNA Polymerase 





and degradation (232). It is likely that the accumulation of diribonucleotides in the 
absence of Orn does not permit viability, but the mechanistic details of how 
diribonucleotides specifically cause toxicity remains to be elucidated. If 
diribonucleotides target specific proteins, their identity could be resolved by 
performing additional screens for proteins that bind diribonucleotides. Alternatively, 
identification of suppressors that promote growth in the absence of Orn might also 
reveal proteins involved in diribonucleotide regulation.  
 While the data in this dissertation reveal the mechanism of diribonucleotide 
processing by Orn in P. aeruginosa, they raise additional questions. How do organisms 
that lack Orn process diribonucleotides and other short RNAs? Are there multiple 
classes of enzymes that specifically process short RNAs? Do any of them specialize in 
other short RNA lengths, other than dinucleotides? Currently, NrnA and NrnB are 
presumed to terminate RNA degradation in a manner functionally redundant to Orn. 
Yet, our preliminary investigations argue against this. Our data suggests that NrnA and 
NrnB have unique substrate preferences, as well as broader substrate preferences 
compared to Orn; therefore, they are not redundant proteins. Future studies will need 
to explore the turnover rate of these enzymes with different substrates, to elucidate the 
enzymology of these proteins and their catalytic strategies. Furthermore, NrnA and 
NrnB may not be co-expressed. NrnB may have a specific role in clearing short RNAs 
during the developmental program of endospore formation, and this should be 
explored. If NrnB is regulated during endospore formation, one would expect to see 





 Moreover, our data continues to raise questions about 5’ cleavage. Our data 
demonstrate that NrnA may act on the 5’ terminus. An experiment that assesses NrnA 
activity against radiolabeled modified RNAs with nonhydrolyzable linkages will help 
determine the direction of NrnA processivity. Comparing cleavage assays for RNA 
substrates containing radiolabeled phosphates at either the 5’ or 3’ termini will also 
help reveal the directionality of NrnA. If these experiments show that NrnA recognizes 
the 5’ end of short RNAs and, moreover, show that it is relevant in vivo, it would be a 
remarkable discovery. The only known 5’-3’ exoribonuclease in bacteria is RNase J 
(261). Our data showing removal of the 5’ residues by NrnA raise an interesting 
hypothesis; the enzyme may act as a 5’-3’ exoribonuclease that specializes in the 
degradation of short RNAs. 
 Interestingly, B. subtilis RNase J (rnjA) was previously tested for orn 
complementation (121). Partial complementation of an E. coli conditional orn mutant 
was observed at low levels of rnjA expression; overexpression of rnjA in the orn mutant 
was lethal. While RNase J showed differing extents of activity against 
oligoribonucleotides in vitro, it was determined that short RNA oligomers were likely 
to be physiologically relevant substrates. Interestingly, a triple deletion mutant of nrnA, 
nrnB, and yhaM was shown to have a negligible effect on exponential growth in B. 
subtilis. This suggests that either RNase J can cleave oligoribonucleotides in the 
absence of the three genes or that additional RNases exist that perform this function. 
Alternatively, the accumulation of dinucleotides is not toxic in this organism, while it 





understanding of how RNAs are degraded in bacteria. Briefly, differences in 
mechanisms of mRNA degradation between E. coli and B. subtilis are addressed below 
 
5.2.1 mRNA Degradation Mechanisms in E. coli 
 In E. coli and other bacteria, RNases cooperate with various interacting partners 
in the form of a large, stable complex called the degradosome (262, 263). The 
degradosome, which localizes to the membrane, is organized around the C-terminal 
half of RNase E. RNase E is responsible for the initiation of mRNA degradation, which 
begins with endonucleolytic cleavage of single-stranded AU-rich regions. RNase E has 
little sequence specificity, and therefore impacts bulk mRNA turnover (264). 
Following endonucleolytic cleavage, distinct sets of exoribonucleases continue to 
degrade mRNA transcripts (232, 265). In E. coli, exonucleolytic cleavage is performed 
exclusively by 3’-5’ exoribonucleases. These include polynucleotide phosphorylase 
(PNPase), RNase II, and R. Despite the fact that the exoribonucleases all act on the 3’ 
end of mRNAs and have been shown to widely overlap with one another, each RNase 
may still have particular substrate specificities. For example, while RNase II has been 
shown to stall upon encounter of a stem-loop, RNase R performs this function readily. 
Furthermore, when a structured region of RNA is encountered, PNPase works in 
conjunction with the helicase RhlB, which assists PNPase in unwinding stem-loops. 
PNPase has also been shown to have both degradative and synthetic capabilities, and 
can add single-stranded adenine-rich tails to the 3’ end of an mRNA transcript. Other 





tRNA and rRNA maturation (232). Finally, while all available literature leading up to 
this study characterized Orn as an additional 3’-5’ exoribonuclease of short RNAs, our 
data reveals that Orn specifically cleaves diribonucleotide substrates, to complete the 
terminal step of RNA degradation.  
 
 
5.2.2 mRNA Degradation Mechanisms in B. subtilis  
 Organisms that lack RNase E use RNase Y instead. RNase Y also initiates 
global mRNA degradation via endonucleolytic cleavage and has been proposed to form 
a complex akin to the E. coli degradosome (266, 267). Like RNase E, RNase Y also 
recognizes single-stranded AU-rich sequences of RNA. B. subtilis not only lacks 
RNase E, but also the 3’-5’ exoribonuclease RNase II. Instead, PNPase, RNase R, and 
YhaM are considered the main 3’-5’ exoribonucleases (268, 269). Like E. coli, B. 
subtilis also encodes RNase PH, which has a primary role in tRNA maturation, but also 
a minor role in mRNA degradation. B. subtilis also features the only known 5’-3’ 
exoribonuclease, RNase J, which cleaves monophosphorylate mRNA transcripts (261). 
Most low-GC Gram-positive bacteria encode two orthologs of RNase J, RNase J1 and 
RNase J2. It has also been argued that RNase J has endonucleolytic activity in vitro 
(270), but the physiological relevance of this activity is still under debate. This theme 
is also addressed in our work—multiple approaches are critical for the assessment of 
enzyme activity, as biochemical experiments alone can produce varied results. 
Interestingly, RNase J is essential in some organisms, but not others (269, 271). While 
essential in Streptococcus pyogenes, the deletion of RNase J in B. subtilis, S. aureus, 





dependence on RNase J1 or J2 is variable across organisms. The deletion of RNase J1 
has a more pronounced effect in some organisms, while others rely more heavily on 
RNase J2.  
 
5.3 Concluding Remarks 
 
 While the general principles of RNA processing and degradation are conserved 
among bacteria, there is no universally conserved set of ribonucleolytic enzymes that 
all bacteria rely upon for mRNA turnover. Our own work highlights aspects of this; 
fluorescent tools described in Chapter 2 reveals which enzymes are able to cleave 
diribonucleotides in vivo. Work discussed in Chapter 3 reveals that in some bacteria, 
Orn is singularly responsible for ‘diribonucleotidase’ activity, and that this is a discrete 
step in RNA degradation. Orn is not encoded in all bacterial genomes, however, and is 
generally encoded in genomes belonging to Betaproteobacteria, Gammaproteobacteria, 
and Actinobacteria. Work discussed in Chapter 4 extends our new knowledge of Orn 
to NrnA and NrnB. NrnA and NrnB have been described as redundant proteins 
generally responsible for cleaving ‘short RNAs.’ Yet our preliminary data suggests that 
NrnA and NrnB are not redundant. NrnA and NrnB exhibit different substrate 
preferences and may have unique cellular functions in Firmicutes, Deltaproteobacteria, 
Actinobacteria, and other phyla. Moreover, while RNase J is currently the only known 
5’-3’ exoribonuclease in bacteria, our work also provides the possibility that a different 
enzyme, NrnA, also acts at the 5’ terminus. RNA degradation is an essential process in 





provides evidence that short oligonucleotides may be processed by unique enzymes in 
discrete steps. However, the mechanisms by which diribonucleotide clearance feeds 
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